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Alcohol (ethanol) is the most widely used of psychoactive
drug and has been known in almost all civilizations since
ancient times (Keller 1979).

There are millions of people

throughout the world who responsibly enjoy consuming
alcoholic beverages served as food, medicines, and
euphoriants.

However, alcohol abuse, alcohol intolerance,

alcohol dependence and other alcohol-related disabilities
are some of the most challenging social, economical and
public health problems facing our modern-day society.

In

the United states alone, the annual cost of lost
productivitity and health expenses related to alcohol is
estimated to be $117 billion (Hoek et al. 1992).
Ethanol is known to cause a wide variety of metabolic
abnormalities. Some of these abnormalities are the direct
effect of ethanol while others are the result of ethanol
induced malnutrition (Lieber 1991).

Ethanol administration

both in humans and laboratory animals, results in
hyperlipidemia, fatty liver, and

ultimately the most severe

stage of alcoholic liver disease: scarring or cirrhosis of
the liver.

It has been recognized that the metabolism of

ethanol plays a major pathogenic role in the etiology of
various diseases associated with alcohol abuse.
Approximately 90% of ingested ethanol is metabolized in the
liver.

The liver enzyme systems able to metabolize ethanol

are; alcohol dehydrogenase (ADH), the microsomal ethanol
oxidizing system (MEOS), and catalase (Larsen 195.9).
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Carnitine (3-hydroxy-4N-trimethylammonium butyrate), an
essential cofactor for facilitating fatty acid transport
into the mitochondrial matrix is synthesized in all mammals,
and consequently is present in diets containing meat
products (Bieber 1988).

Sachan et al. found that carnitine

supplementation lowered ethanol-induced increases of various
lipid fractions in rat's liver (Sachan and Rhew 1983, Sachan
et al. 1984) in a dose related manner (Rhew and Sachan
1986).

They hypothesized a state of functional carnitine

deficiency in chronic alcoholism and proposed that dietary
carnitine supplementation may prevent ethanol-induced
hepatic diseases.

Further, they demonstrated that dietary

carnitine supplementation elevated blood ethanol
concentration (BEC) following both acute and chronic doses
of ethanol and the increase in BEC was dependent on the
level of carnitine supplementation (Berger and Sachan 1986,
Sachan and Berger 1987, Berger and Sachan 1991, Sachan
1992).

This effect of carnitine is specific to carnitine

since it could not be reproduced by choline (Sachan and
Berger 1993).

It was also shown that at 6 hours post

ethanol administration on the third day of carnitine and
ethanol treatment, there was significantly higher (96%)
hepatic ethanol concentration (HEC) in the non-supplemented
rats than in the carnitine supplemented rats without changes
in activities of ethanol metabolizing systems (Mynatt and
Sachan 1992, Sachan 1992).

Those results suggested that
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carnitine may modulate enzyme systems via some type of
mediator or may be affecting membrane permeability to
ethanol.
The main objective of the first study, therefore, was to
explore mechanism of carnitine-mediated attenuation of
ethanol metabolism by:
1. Determining the effects of carnitine on ethanol
metabolism in isolated hepatocytes.
2. Establishing specificity of carnitine inhibition on
ethanol metabolism in the hepatocytes.
The results of first study showed that, acetylcarnitine, a
metabolite of carnitine, was a far more potent inhibitor of
These

ethanol oxidation in hepatocytes than was carnitine.

results were encouraging in that it explained the lag time
in carnitine response in the intact animal (Sachan 1992) and
the lack of inhibition of ethanol metabolizing enzymes by
carnitine (Mynatt and Sachan 1992).
The main purpose of the second study, therefore,

was to

reinvestigate mechanism of carnitine-mediated attenuation of
ethanol metabolism at the enzymatic level by:
1.

Determining the inhibitory effect of
acetylcarnitine on ethanol metabolizing enzyme(s),
ADH.

2.

Investigating the mechanism of acetylcarnitgwe
interaction with ADH.
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ETHANOL METABOLISM

Ethanol is absorbed primarily from the small intestine
(80%) by simple diffusion and is distributed throughout the
total body water, accumulating in tissues with the highest
water content (Goldstein 1983) .

Studies with experimental

animals have shown that the liver is the principal organ
responsible for ethanol metabolism (Hawkins and Kalant
1972) .

The firs� step in the metabolism of ethanol is its

oxidation to acetaldehyde.

This conversion is carried out

almost entirely in the liver, although other tissues have
some oxidative capacity (2-10%) .

Enzyme systems that can

catalyze the oxidation of ethanol to acetaldehyde are
alcohol dehydrogenase (ADH) , catalase, and the microsomal
ethanol-oxidizing system (MEOS) (Li 1977, Branden et al.
1975) .
Liver ADH is a soluble enzyme that uses nicotinamide
adenine dinucleotide (NAD + ) as a coenzyme in conversion of
ethanol to acetaldehyde according to the reaction shown
below.

The details are discussed in ADH review section

(page 19) .

Microsomal fractions of liver contains microsomal
ethanol-oxidizing system (MEOS) , which can oxidize ethanol
in the presence of molecular oxygen and NADPH.

The

9
mechanism involves cytochrome P-450 mediated hydroxylation
of carbon one of ethanol with concomitant oxidation of NADPH
(Lieber 1991) according to the following reaction.

Lieber

and.colleagues have characterized this system and believe
that it is responsible for a substantial part of the ethanol
metabolism in the liver, especially at high and chronic
ethanol consumptions (Lie�er et al. 1987).

In rats, chronic

feeding of ethanol increases MEOS activity, hepatic
microsomal protein, smooth endoplasmic reticulum, and
cytochrome P-450 (Goldstein 1983).

One possible explanation

is that at low concentrations of ethanol, ADH is already
saturated and at higher ethanol concentrations, the MEOS has
the ability to oxidize more ethanol.

This would be

consistent with the known enzyme kinetics of the two systems
since the Km for ethanol in ADH system is around 2 mmol. L-1
and the Km for ethanol in the MEOS is around 10 mmol. L-1•
Recently, P-450 IIEI which is a 52, 000 dalton protein, has
been purified by immunoelectrophoresis and shown to be
inducible by ethanol (Shimizu 1990).

Since MEOS uses both

NADP/NADPH and NAD/NADH coenzymes, ethanol oxidation via
MEOS could result not only in accelerated ethanol
metabolism, but it may also accelerate the ADH pathway by
favoring the re-oxidation of NADH (Domschke et al. 1974).
Catalase is a peroxisomal enzyme that can cata�yze the

10

peroxidative cleavage of ethanol to acetaldehyde in the
presence of a H202 generating system.

The contribution of

cataJuc

catalase in ethanol oxidation is quite small because the
physiological rate of H202 production is rather low (Lieber
et al. 1987, Li 1977) .

However, there is evidence pointing

to significantly larger than accepted rate of ethanol
metabolism by catalase (Bradford et al. 1993) .
The next step in the completion of ethanol oxidation is
the oxidation of acetaldehyde to acetate catalyzed by
aldehyde dehydrogenase (ALDH) .

ALDHs are a group of enzymes

catalyzing the conversion of aldehydes to corresponding
acids via a NAD + -dependent irreversible reaction (Ikawa et
al. 1983) .

A more detail review of ALDH is given in the

later section (page 19) .
studies using liver perfusion, liver slices and
hepatocytes have shown that acetate from ethanol is further
metabolized in the liver.
recovered as

14C0
2

The [ 1-14C]-ethanol was partially

and TCA cycle intermediates (Dajani and

Orten 1962, Forsander et al. 1965, Smith 1961) , indicating
further oxidation of acetate in the liver rather than in the
extrahepatic tissues.
The incorporation of radioactive carbons of

14

C-ethanol
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into acetoacetate, �-hydroxybutyrate, triglycerides and
cholesterol indicates that acetate is also utilized for
synthesis of these compounds in the liver (Smith 1961).
EFFECTS OF ETHANOL OH LIVER

In the early part of this century, dietary deficiencies
were considered to be the major cause of ethanol-induced
liver diseases.

However, even in the absence of dietary

deficiencies ethanol can lead to the development of liver
diseases in humans (Lieber et al. 1962).

More recently, it

has been shown that ethanol, as well as malnutrition which
has been induced by ethanol, contributes to liver diseases
(Lieber 1991).

Because ethanol is rich in energy ( 7. 1

Kcal. g-1 ), a large intake of ethanol has profound effects on
nutritional status (Scheig 1970).

over consumption of

ethanol may cause primary malnutrition by displacing other
nutrients in the diet because ethanol lacks essential
nutrients other than calories (empty calories).

Secondary

malnutrition may result from either maldigestion or
malabsorption of nutrients caused by gastrointestinal
complications.

Such primary and secondary malnutrition can

induce deficiency of virtually all nutrients (Lieber 1990).
Many disturbances in intermediary metabolism and toxic

effects can be linked to (1) acetaldehyde, the product of
ethanol oxidation, (2) ADH-mediated generation of NADH and
(3) the induction of the microsomal enzymes, especially
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P-450 IIEl (Lieber 1991) as shown in Figure 2.1.

First,

ethanol oxidation results in production of acetaldehyde
which in turn, causes liver injury through a variety of
mechanisms due to its nature of high chemical reactivity.
Acetaldehyde causes glutathione depletion, lipid
peroxidation (Lieber 1991), and stimulates hepatic collagen
synthesis (Irving et al. 1991), thereby promoting fibrosis
and cirrhosis.

Second, ethanol oxidation in the cytoplasm

via ADH results in a stoichiometric reduction of NAO + .
Since the mitochondrial membrane is impermeable to NADH,
reducing equivalents must be transferred into the
mitochondria via the a-glycerophosphate or malate shuttle
(Thurman 1977).

The oxidation of ethanol in the hepatocyte

increases the NADH/NAD ratio (Forsander et al. 1965,
Domschke et al 1974).

This increased NADH/NAD ratio is

responsible for many of the deleterious effects of ethanol,
such as ketosis, hyperlipidemia (Mendenhall 1972),
hyperuricemia (Lieber 1962), and fatty liver (Lieber 1988).
The activity of hepatic MEOS, especially, P-450 IIEl can be
induced even after short-term and relatively light
consumption of ethanol {Lieber et al. 1988).
Induced cytochrome P-450 affects drug metabolism and
enhances the rate of drug clearance from the blood (Kater et
al. 1969).

Ethanol pretreatment remarkably stimulates the

toxicity and carcinogenicity of xenobiotics such as CC14
(Hasumura et al. 1974) and bromobenzene {Hetu et al. 1983).

-

::::::::,,�<
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PIGURE 2.1. oxidation of ethanol in the hapatocyte (Lieber 1991)
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ETHANOL METABOLISM IN ISOLATED HEPATOCYTES

Isolated, rat hepatocytes have been used for ethanol
oxidation studies under controlled conditions.
To relate the results of studies with isolated cells to
ethanol metabolism in vivo, a major difference between
isolated hepatocytes and the liver in vivo must be
considered.

A summary of many studies indicates that the

rate of ethanol oxidation in rats in vivo is from 2. 4 to 4. 0
µmol. min·1. g·1 of wet weight of liver (Cornell et al. 1977).
In isolated rat hepatocytes, however, the rates are much

lower from o. 7 to o. 9 µmol. min·1• g·1 of wet weight of cells
when these cells are incubated with ethanol and no other
substrate is added (Krebs & Stubbs 1975, Crow et al. 1978).
Therefore, hepatocytes that are properly prepared and
maintained provide an excellent in vitro system for studying
liver ethanol metabolism because the isolated cells retain
the same metabolic capacities as the intact liver (Cornell
et al. 1977).

Isolated hepatocytes are also a good system

for studying ethanol metabolism in liver because the
experimental conditions can be easily controlled.
Effect of ethanol concentration

Many studies have shown that a single large dose of
ethanol increases the rate of ethanol oxidation in
experimental animals (Yuki and Thurman 1980, Yuki et al.
1980), and in vitro preparations of liver such as liver
perfusion and hepatocyte preparation (Yuki et al. -1982).

It
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has also been shown in vitro that rat-liver parenchymal
cells oxidized ethanol at a rate of 2. 5 µmol. min�. m� 1 packed
cells at 65 mmol. L-1 ethanol concentration, which was 1. 85
times the oxidation rate at 4 mmol. L-1 ethanol.

At ethanol

concentrations above 10 mmol. L-1 a significant increase in
the ethanol oxidation rate was observed compared to the
oxidation rate at 4 mmol. L-1 (Grunnet et al. 1973) •

This

phenomenon has been named the "swift increase in alcohol
metabolism".

The increased oxidation rates attributed to

the presence of a high-Km MEOS (Goldstein 1983).

An

accompanying increase in liver 02 uptake with large ethanol
dose has also been observed (Yuki and Thurman 1980), which
may be explained by the following sequence of events:
ethanol increases the NADH redox state, which inhibits
glycolysis because it is a NAD + dependent pathway.

since

the glycolytic pathway is an ATP-generating sequence,
inhibition of glycolysis makes more ADP available to
stimulate mitochondrial electron transport, and increase
oxygen uptake (Thurman 1977).

In contrast to the above

studies, other investigators have shown that ethanol is
metabolized at a constant rate over a wide concentration
range; however, a significant increase in 02 uptake is found
after acute ethanol pretreatment in hepatocytes isolated
from starved, but not from fed, rats (Stowell and crow
1985).

In one study ethanol was oxidized more slowly by

rats which were given an ethanol dose of 5. 1 g. Kg� than by
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rats which were given an ethanol dose of 1. 4 g. Kg·1 (Braggins
and Crow 1981).

This is not consistent with the previous

explanation that a high Km MEOS and the rate of NADH
reoxidation play an important role in determining ethanol
oxidation rates and that the rates of ethanol metabolism are
closely linked to the rates of 02 uptake.

The alternate

explanation is that ethanol was oxidized more slowly at high
ethanol concentrations because ethanol itself was an
inhibitor of rat liver ADH.

It was also shown that

increases in 02 uptake with ethanol pretreatment may not
lead to an increased rate of ethanol metabolism.

Therefore,

the activity of ADH is the major factor limiting rates of
ethanol oxidation in vivo (Braggins and Crow 1981).

Some of

these observations may be due to the different experimental
conditions such as using different strain of animals,
duration of starvation of rat, perfusion technique,
incubation medium, etc. For example, the effects of ethanol
on 02 uptake by liver depend entirely on the initial state
of the liver.
Fructose effect

It has often been reported that fructose causes a marked
acceleration of ethanol oxidation in perfused liver and
isolated hepatocytes (Berry and Kun 1978, Grunnet et al.
1973, Scholz and Nahl 1976).

Scholz and Nahl (1976) have

suggested that fructose accelerates ethanol oxidation by
increasing the rate of intramitochondrial reoxidation of
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NADH due to an increased ATP demand for gluconeogenesis.
However, other gluconeogenic precursors such as sorbitol,
which also increase respiration, have no stimulatory effect
on ethanol oxidation.

The stimulation of ethanol oxidation

by fructose was completely abolished by 4 mmol. L-1 pyrazole
(ADH inhibitor), indicating that the "fructose effect" was
mediated via ADH (Berry and Kun 1978).
Effects of pyruvate and lactate

Pyruvate increased the oxidation rate of ethanol in
isolated rat-liver cells by 130-240 % (Grunnet et al. 1973).
_An apparent explanation for pyruvate induced acceleration in
ethanol metabolism by isolated liver cells is the rapid
reoxidation of cytosolic NADH via lactate dehydrogenase
reaction which provides conditions more favorable for
ethanol oxidation by ADH.

By a similar reasoning, it might

be expected that lactate added to hepatocyte suspensions
would inhibit ethanol metabolism, since lactate oxidation
produces NADH and competes with ADH for free cytosolic NAO + .
It is well documented, however, that lactate increases
the rate of ethanol oxidation in hepatocytes (Crow et al.
1978, Krebs and Stubbs 1975).

It has been suggested that

substrates for glucose synthesis, such as lactate and
pyruvate, accelerate ethanol oxidation, as a result of
increased ATP utilization for glucose production
(gluconeogenesis).

Cornell et al. (1977) conducted

experiments with quinolinate and tryptophan because these
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compounds block gluconeogenesis in the rat by inhibiting
phosphoenolpyruvate carboxykinase, thereby preventing 2/3 of
the ATP utilization required in the synthesis of glucose
from lactate or pyruvate (Ray et al. 1966, Veneziale et al.
1967).

They found that quinolinate and tryptophan both

effectively decreased glucose synthesis, but neither
inhibitor had any effect on the lactate or pyruvate
stimulated rate of ethanol metabolism (Cornell et al. 1977).
These results indicate that lactate or pyruvate stimulated
oxidation is not due to an increased ATP demand for glucose
synthesis.

Alternatively, it has been proposed that lactate

stimulation of ethanol oxidation in hepatocytes is due to an
increase in malate and aspartate concentrations (Meijer et
al. 1975) which would increase reoxidation of cytosolic NADH
via the malate aspartate shuttle (Crow et al. 1983).
In summary, the malate-aspartate shuttle (which controls
reoxidation of NADH) intermediates may be rate determining
step in ethanol metabolism by hepatocytes under some
conditions (particularly in the fasted state) because
shuttle intermediates (malate, glutamate, and aspartate) are
lost during cell preparation (Cornell 1977, Krebs et al.
1975), which is not the case in vivo.

The rate of ethanol

oxidation is limited by the level of cytosolic NADH which
limits the rate of ethanol oxidation by ADH.
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Alcohol dehydrogenase(ADR, EC 1.1.1.1) and Aldehyde

dehydrogenase(ALDR, EC 1.2.1.3)

ADH and ALDH are the major·enzymes involved in the
initial two steps of ethanol metabolism.

ADH is universally

distributed in living organisms, occurring in
·microorganisms, plants, and animals (Pietruszko 1983) .
Yeast and mammalian alcohol dehydrogenase differ in
substrate specificity and rate of catalytic activity
(Branden et al. 1975) .

In mammals, this enzyme occurs in

highest concentration in the liver, where it is found in the
cytoplasmic fraction (Raskin and Sokoloff 1972) .

Liver ADH

exists in multiple molecular forms that arise from the
association, in various permutations, of different types of
subunits (Strydom and vallee 1982) .

Extrahepatic tissues

contain isozymes of ADH with a much lower affinity for
ethanol than the hepatic isozymes: as a consequence, at the
concentrations of ethanol reached in the blood, the.
extrahepatic enzymes are inactive, and therefore,
extrahepatic metabolism of ethanol is negligible (Manautou
and Carlson 1992) , with the exception of the
gastrointestinal tract (Algar et al. 1992) .

Human and

rodent ADH exists as a heterogeneous group of isozymes that
can be placed into three categories based upon structural
and functional distinctions (Strydom and Vallee 1982) .
Class I ADH is encoded in humans by three closely related
genes ADHl, ADH2, and ADH3 showing differential tissue-
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specific and temporal expression during human development
{Smith 1989).

Class I ADH functions as both an ethanol

dehydrogenase for detoxification of ingested ethanol {Li
1977) and as a retinol dehydrogenase for retinoic acid
synthesis {Mezey and Holt 1971).

Ethanol is the classical

human class I ADH substrate and acts as a competitive
inhibitor of retinol oxidation in human liver extracts.
Liver has consistently higher class I ADH activity than
other tissues, whereas class I I I ADH activity is present in
practically all tissues {Danielsson et al. 1992).
Human class I I ADH reduces an aldehyde intermediate in
norepinephrine metabolism {Ooij et al. 1992).

The

distribution of class II isozymes changes between species.
In humans, the class I I isozyme has been reported only in
the liver, whereas in the rat, the ADH 2 isozyme is
characteristic of the digestive tract and external organs
such as skin, cornea, tongue, etc. , but is not found in the
liver {Boleda et al. 1989).

Human class I I I ADH catalyzes

an omega-oxidation step in leukotriene B4 synthesis in
neutrophils {Gotch et al. 1990).

Also, human class I I I ADH

has been identified as the glutathione-dependent
formaldehyde dehydrogenase that is involved in elimination
of formaldehyde produced as a by product of certain
metabolic reactions {Jornvall et al. 1991).
Rat tissues contain three different isozymes of ADH.
ADH 1 is an anodic isozyme present in high amount& in the

Rat
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ocular tissues (Pares et al. 1985), stomach and lung.
ADH 1 has intermediate properties, with a Km for ethanol of
340 mmol. I;1 , a broad substrate specificity and Ki for
pyrazol of 0. 56 mmol. I:1 •

Rat ADH 2 is also anodic and has

been found in all the rat organs examined (Julia et al
1986).

ADH 2 has substrate specificity for long-chain

alcohols and aldehydes, cannot be saturated by ethanol and
is practically insensitive to pyrazol (Ki=78. 4 mmol. L-1 ).
Rat ADH 3 is the group of cathodic ADH's, are mainly present
in the liver, and plays a major role in ethanol metabolism
(Julia et al. 1987).

ADH 3 exhibits a Km for ethanol of 1. 4

mmol. I;1 , a broad substrate specificity and is strongly
inhibited by pyrazole (Ki=0. 4 µmol. L�).

There is

approximately 80% sequence homology among subunits of human
and rat liver ADH (Jornvall and Markovic 1972).

Rat ADH 1,

ADH 2 and ADH 3 exhibit many analogies with human .ADH
classes II, I I I and I respectively (Pares et al. 1985).

In

the rat, ADH 3 and to some extent ADH 1 are the primary
isozymes for external alcohol metabolism whereas ADH 2 may
be more important for the metabolism of the endogenous long
chain alcohols and aldehydes (Julia et al. 1987, Julia et
al. 1986).
2. 1.

Human and rat isozymes are summarized in Table

In investigations of the interaction in vitro between

liver ADH

and a large number of heterocyclic compounds,

pyrazol was found to be a most potent inhibitor of ADH.
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TABLE 2.1
Summary of human and rat ADB isozyaes

Species

Isoenzyme

Location

Specificity and
function

Human

Class I

Liver

Class II

Liver

Ethanol oxidation
Synthesis of
retinoic acid
Norepinephrine
metabolism

Class III

All tissues

Synthesis of
leukotriene

ADH 1

Ocular
Stomach
Lung

Anodic
High Km - ethanol

ADH 2

All tissues

Anodic
Long chain ethanol
oxidation
Insensitive to
pyrazol

ADH 3

Liver

Cathodic
Ethanol oxidation
Inhibited by
pyrazol

Rat
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Pyrazole was shown to have a dose-dependent inhibitory
effect on ethanol metabolism , ED� in the rat being 0. 290. 43 m mol. kg·1 pyrazol (Goldberg and Rydberg 1969) •

Studies

in rats on the effects of various pyrazole analogues and
other compounds on ethanol metabolism demonstrated that a
dose of less than 0-5 mmol. L-1 pyrazol per kg resulted in an
inhibition in the rate of ethanol elimination by more than
25% of control value (Golfberg and Rydberg 1969).
Therefore, pyrazole and its analogues are widely used to
inhibit ADH and to block the metabolism of ethanol (Wendell
-�nd Thurman 1979, Grunnet et al. 1973, Yuki et al. 1982,
Feierman and Cederbaum 1987).

The essential mechanism of

action in vivo is most probably the same as the in vitro
inhibition of the ADH.

Pyrazole is a competitive inhibitor

of ADH on ethanol oxidation, which is consistent with the in
vivo findings that a dose-response relationship exists
between degree of inhibition and dose of pyrazol (Goldberg
and Rydberg 1969).

Other inhibitors of ADH are summarized

in Appendix 8.
Like ADH, NAO-linked ALDH occurs primarily in the liver,
with much lower concentrations in other organs. ADH occurs
exclusively in the cytoplasm, whereas the ALDH activity is
distributed among different subcellular compartment
(Marjanen 1972).

The majority of the ALDH activity in the

rat is localized in the mitochondria, but the enzyme also
occurs in the cytoplasm, microsomes, and other membranes.
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Two major and several minor isozymes exist in the mammalian
liver including man.

One of the major isozymes, designated

as ALDHl or El is associated with slower anodal
electrophoretic mobility, a low Km for NAD, and a high Km
for acetaldehyde.

Another major isozyme, designated as

ALDH2 or E2, is associated with faster anodal
electrophoretic mobility, a high Km for NAO, and a low Km
for acetaldehyde (Tottmar et al. 1973).

ALDHl isozyme is of

cytosolic origin and ALDH2 of mitochondrial origin (Vallari
and Pietruszko 1984).
There is some evidence that the interaction of alcohol
and hormones may be mediated by ALDH (Maxwell and Topper
1961).

Ethanol has also been reported to cause alterations

in the steady state levels of biogenic amines through
alterations in the rates of ALDH metabolism of biogenic
aldehydes (Tank et al. 1976).

Thus, ALDH may play a

physical role in the metabolism of aldehydes arising from
corticosteroid and biogenic amine hormones.
Although it is exceedingly rare in persons of European
ancestry, in about 50-70 % of Orientals there is a
deficiency of the ALDH enzyme (isozyme ALDHl) that
metabolizes acetaldehyde to acetate (Goedde and Agarwal
1983).

The deficiency is responsible for high

concentrations of acetaldehyde after the ingestion of
ethanol.

Acetaldehyde has pronounced effects on the body,

including shortness of breath, facial warmth (flushing),

25

decrease in blood pressure, and increase in heart rate
(Agarwal and Goedde 1990).

These effects of acetaldehyde

are generally perceived to be·unpleasant, so it is easy to
understand why this population, called flusher, become
alcoholics far less frequently than nonflushers.
Disulfiram (Antabuse) and Calcium Carbamide (Temposil)
are drugs that are sometimes given in the treatment of
alcoholism (Giles and Kapur 1991, Pirola 1978).

These drugs

block the conversion of acetaldehyde by inhibiting ALDH
enzyme (Giles and Kapur 1991).

Drugs and chemicals that

have disulfiram-like activity include cyanamide (Hald et al.
1952), hypoglycemic sulphonylureas (Truitt et al. 1962),
anti-parasitic agent, metronidazole, (Lal 1969), and
antimicrobial drug, furazolidone, (Perman 1965).
CARNITINE AND ETHANOL METABOLISM

Carnitine facilitates the transport of fatty acids, via
carnitine acyltransferase, into the mitochondria for�
oxidation {Fritz et al. 1962).

Without carnitine, most of

the fatty acids that are eaten by humans could not be
metabolized for energy and thus an important energy source
would be eliminated and the fatty acids would be stored in
adipose tissue (Bieber 1988).

Because of the unique role of

carnitine in the transport of fatty acids into mitochondria
(Fritz et al. 1962) as well as among different organs
(Hoppel et al. 1980), investigators studied the possibility
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that carnitine might help prevent the ethanol-induced liver
diseases.

Hosein and Bexton (1975) reported that carnitine

had a protective effect on lipid metabolism rat fed ethanol.
They found that carnitine (0. 1 mg. g·1 B. W. ) significantly
lowered serum triglycerides in rats which received ethanol
(6 g. k�1 B. W. ).

It also significantly reduced hepatic

triglycerides in rats injected with ethanol
intraperitoneally (4 g. kg-1 B. W. ).

carnitine depletion in

patients hospitalized for advanced cirrhosis was shown by
Rudman et al. (1977).

Fasting serum carnitine concentration

was measured in 16 normal people and 247 cirrhotic patients.
They found that the cirrhotic group showed significantly
lower total and free carnitine than the normal group.
In recent studies undertaken to study the possible effect
of dietary carnitine supplementation on ethanol-induced
hepatic steatosis, it was observed that carnitine
supplementation lowered ethanol-induced increases of various
lipid fractions ( Sachan et al. 1984, Sachan and Rhew 1983).
They found that supplementation of carnitine in liquid
alcohol diet (36 % calories as ethanol)

significantly

lowered total lipids, free and esterified cholesterol,
triglycerides, and phospholipids in the liver.

Later, it

was found that the effect was dose dependent up to 0. 8 % of
DL-carnitine supplement (Rhew & Sachan 1986).

Intravenous

administration of L-carnitine to humans significantly
reduced ethanol-induced increase of blood acetate-and
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promoted urinary excretion of acetylcarnitine following
ethanol administration (Adamo et al. 1988).

When rats were

administered an acute oral dose of ethanol (Jg. Kg-1 B. W. ),
the animals supplemented with 1 % DL-carnitine for 3, 5, and
10 days had significantly higher blood ethanol
concentrations (BEC) from 2 to 8 hours post ethanol
administration than non-supplemented rats (Berger and Sachan
1986, Sachan and Berger 1987).

The increase in BEC was

dependent on the level of carnitine supplementation and the
0. 5 % L-carnitine supplementation for 3 days produced
maximum BEC (Berger and Sachan 1991, Sachan and Berger
1993).

They found that carnitine did not alter the rates of

ethanol appearance in the portal blood, but it significantly
elevated the systemic BEC during the same initial 30 min.
So, they concluded that carnitine retarded ethanol
metabolism without altering the rate of ethanol absorption
from the small intestine.

Since the simultaneous

administration of carnitine with ethanol did not attenuate
ethanol metabolism (Sachan 1992), it was proposed that
carnitine may modulate enzyme systems or cell structure in
some type of inductive manner (Mynatt 1989).

Carnitine

supplementation significantly reduced ( 1-14C]-.ethanol
oxidation to Mco2 and increased plasma concentrations of
lactate 2. 5 times which resulted in a higher
lactate/pyruvate ratio.

Carnitine supplementation, however,

did not significantly affect the ethanol and acetaldehyde
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metabolizing enzyme activities (Mynatt and Sachan 1992).
The shift to a more reduced redox state by carnitine
supplementation was hypothesized to be the possible
mechanism for the attenuation of ethanol oxidation by
carnitine.

In conclusion, it was suggested that carnitine

may modulate enzyme systems via some type of mediator or it
may be affecting hepatocyte's permeability to ethanol.

As a

result ethanol oxidation in the isolated hepatocytes was
examined to understand the mechanism of carnitine-mediated
attenuation of ethanol metabolism.
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ABSTRACT

Previous studies have shown that supplementary carnitine
protected liver from fatty infiltration caused by ethanol.
One of the reasons was that carnitine retarded ethanol
clearance and hence its metabolism in the intact rat.
However, in vitro activities of ethanol metabolizing enzymes
were not significantly altered by carnitine.

Therefore,

hepatocytes were targeted to understand the mechanism of
action of carnitine on ethanol metabolism.

The cells were

isolated from male Sprague Dawley rats by a collagenase
perfusion technique.

Hepatocytes were incubated in albumin

containing medium with ethanol in presence or absence of
added L-carnitine or related compounds.

Ethanol oxidation

was determined by the loss of ethanol as well as by the
products formed against time, cell numbers and ethanol
concentrations.

The rate of ethanol oxidation in presence

of L-carnitine was one half the rate in absence of carnitine
(24. 69 nmol. min·•. million·1 cells) •

Further it was found that

choline mimicked carnitine effect and L-acetylcarnitine was
100 times more active than L-carnitine in inhibiting ethanol
oxidation in the isolated hepatocytes.

The effect was dose

related for both carnitine and acetylcarnitine,

however,

there was a definite lag time for carnitine effect.

The

products of ethanol oxidation in presence of acetylcarnitine
suggested that site of inhibitory action must be ADH.
these results it is concluded that carnitine is

From

converted
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to acetylcarnitine which in turn inhibits ethanol metabolism
in the isolated hepatocytes and the intact rat.
INTRODUCTION

Alcoholism is a major social, economical and public
health problem throughout much of the world.

In the United

states alone, the annual cost of lost productivitity and
health expenses related to alcoholism is estimated to be
$117 billion (Hoek et al. 1992) .

Alcohol (ethanol) is known

to cause a wide variety of metabolic abnormalities (Agarwal
and Goedde 1990) .

Ethanol administration both in humans and

laboratory animals results in hyperlipidemia and fatty liver
(Lieber et al. 1987) .
Carnitine (3-hydroxy-4-N-trimethylammonium butyrate) is
widely distributed in living organisms and is biosynthesized
in mammals.

The foods of animal origin especially, milk and

meats are rich dietary sources of carnitine.

It is an

essential cofactor for facilitating fatty acid transport
into the mitochondrial matrix where �-oxidation takes place
(Fritz et al. 1962) .

Without carnitine, most of the

ingested fatty acids would not be fully metabolized for
energy and thus an important production, and the body would
be forced to store the fatty acids as triglycerides in
adipose tissue (Bieber, 1988) .
In recent studies supplementary carnitine has been shown
to minimize ethanol-induced hepatic steatosis in a dose
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dependent manner (Sachan et al. 1984, Rhew and Sachan 1986).
The underlying mechanism involved retarded clearance of
blood-ethanol due to attenuation of ethanol metabolism in
the intact rat (Berger and Sachan 1986, Sachan and Berger
This effect of carnitine is

1987, Berger and Sachan 1991).

specific to carnitine since it could not be reproduced by
choline (Sachan and Berger 1993).

Further, it is known that

hepatic ethanol concentrations are higher in carnitine
unsupplemented than supplemented rats (Mynatt 1989).
Carnitine reduced oxidation of

C-ethanol to

14

C02 in the

14

intact rat, however, the in vitro activities of ethanol
metabolizing enzymes were not significantly affected by
carnitine (Mynatt and Sachan 1992).

These results suggested

that carnitine may modulate enzyme systems via some type of
mediator or may be affecting membrane permeability to
ethanol.
Therefore, the main obj ective of this study was to
explore mechanism of carnitine-mediated attenuation of
ethanol metabolism using rat hepatocytes.

The specific

obj ectives were to determine in vitro effects of carnitine
on ethanol metabolism in isolated hepatocytes and to
establish specificity of the carnitine effect.

Ethanol

oxidation in rat hepatocytes was determined against time,
cell numbers and ethanol concentration in presence or
absence of L-carnitine as well as carnitine like compounds.
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MATERIALS AND METHODS
Chemicals.

L-acetylcarnitine and r-butyrobetaine were

obtained from Aldrich Chemical Co. (Milwaukee, WI).
Collagenase (Type IV), HEPES (N-2-hydroxy ethylpiperazine),
L-carnitine, DL-carnitine, choline, L-acetylcholine, P-OH
butyrate, L-lysine, and palmytylcarnitine were purchased
from Sigma Chemical Co. (St. Louis, MO).

Bovine serum

albumin (BSA) was obtained from ICN Pharmaceuticals, Inc.
(Cleveland, Ohio).

Ethanol was purchased from Quantum

Chemical Co. (Tuscola, IL).

Ethanolamine was obtained from

Fisher scientific Co. (Fair Lawn, NJ).

( 1- 14C ] -ethanol was

obtained from New England Nuclear (Boston, MA).

All other

chemicals were from Baxter Diagnostics Inc. (McGaw Park, IL).
Animals and diets.

The experimental protocol was

approved by the University of Tennessee animal care
committee.

Male Sprague-Dawley rats (Harlan Sprague Dawley

Inc. , Indianapolis, IN) with an average body weight . of about
250 g were individually housed in 7" x 10" x 7" stainless
steel wire mesh cages.

Room temperature was maintained at

22 ° C ± 1 ° C and constant relative humidity (52%) with a 12
hour light-dark cycle.

All specifications of the animal

facility complied with AAALAC regulations.

All animals had

free access to rat chow (Agway Prolab #3000, Syracuse, NY)
and

hyperchlorinated city ,water.

Hepatocyte preparation.

About 8 : 30 A. M. on the day of

experiment, a rat was anesthetized by Metofane (Pitman-
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Moore , Inc. Mundelein , IL).

The abdominal cavity was opened

and portal vein was surgically cannulated.

The liver was

perfused and hepatocytes were isolated according to the
method described by Seglen (Seglen 1976) with some
modification (Horne et al. 1976).

The procedure is

described in detail in appendix I.
modification is as follow:
was 0. 0 5 % (w/v).

A brief account of the

The concentration of collagenase

ca + + -free perfusion buffer for the

preparation of the cells was replaced by the physiological
saline Krebs-Henseleit buffer , KHB (Krebs 1974) and solution
for the final incubation was replaced by KHB saline
containing 2. 5% (w/v) BSA.

The buffer solutions including

collagenase buffer were gassed with 02: C02 mixture (95: 5) for
at least 10 min and ca + + free buffer was gassed throughout
the liver perfusion.

The cells released by collagenase

treatment were filtered though a nylon mesh (size 0. 5 mm x
0. 3mm). All hepatocyte preparations were washed and - cell
viability was determined by Trypan Blue exclusion (Crow et
a l. 1978).

The hepatocyte concentration was standardized ,

kept at room temperature and used for study within hours
after preparation.
Ethanol metabolism in hepatocytes .

The incubation was

carried out in a 25 mL Erlenmeyer flask in total volume of 4
mL KHB (pH 7. 4) with 2. 5 % BSA.

The hepatocytes in the

incubation mixture was one million cells. mL"1 (24 million
cells

=

1 g wet cell weight).

The standard incubation
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mixture contained KHB with 2. 5 % BSA, hepatocytes (million.
mL·1 ) , ethanol (10 mmol. L-1 ) , and carnitine or related
compound (200 µmol. L-1 ) in 4 mL.

Whenever necessary

deviation in the concentration of component was made as
indicated in that experiment.

The flask was flushed with

mix of 02: C02 (95: 5) before adding ethanol to get the
predetermined concentration (usually 10 mmol. L-1 ) in the
incubation mixture.

The flask was sealed with rubber

stopper and incubated in a Dubnoff water bath with shaking
(80 oscillation. min�) at 37 ° C.

A control flask was

prepared for each flask in which 0. 2 mL of 60% HC104 was
added prior to addition of ethanol and rest of the
incubation procedure was identical to that of test flask.
The reaction was terminated by injecting 0. 2 mL of 60% HC104
with a syringe.

The contents were mixed well, and cooled in

ice bath for 30 minutes.

The mixture was centrifuged in a

centrifuge (Backman TJ-6R, 2000 x g) at 4 ° C for 1o · minutes
and supernatant was separated and assayed for ethanol by the
enzymatic method (Bernt and Gutmann 1974).
Oxidation of ethanol to CO2 was determined using ( 1- 14C ] ethanol.
flask.

The incubation was carried out on a 25 mL Warburg
The standard incubation mixture contained KHB with

2. 5 % BSA, hepatocytes (million. mL-1 )

,

[ 1- 14C ] -ethanol (10

mmol. L-1 ) , and carnitine or related compound (2 o o µmol. L-1 )
in 3 mL.

Whenever necessary, deviation in the concentration

of component was made as indicated in that experiment.

The

43
center well contained 0 . 2 mL of ethanolamine (100 % ) and
side arm contained 0 . 2 mL of 60 % HC104 •
gassed with a mix of 02 : CO2
[ l-14C] ethanol.

(

The flask was

95: 5) before adding 1 O mmol. L-1

The flask was sealed with rubber stopper .

Incubation was carried out at 37 ° C in Dubnoff metabolic
shaking water bath (80 oscillation . min� ) .

The reaction was

terminated by tipping HC104 from the side arm into
incubation mixture .

The flask was allowed to shake an

additional 60 min at 37 ° C to allow absorption CO2 in the
ethanolamine.
30 min.

The flask was well chilled in ice water for

Ethanolamine was transferred from center well to

scintillation vial. Residual ethanolamine was wash out 3
times with scintillation fluid, 5 mL of scintillation fluid
was added to the vial, and radioactivity was counted in a
Beckman LS 3801 Liquid Scintillation system (14C02 )

• ,

The

HC104 treated incubation mixture was centrifuged with in a
Beckman TJ-6R tabletop centrifuge (2000 x g ) at 4 ° C for 10
minutes and SN, pellet were separated, and frozen for the
analysis of metabolites.
The pellet was extracted for Lipids with 2: 1 of
chloroform-methanol mixture and insoluble substances were
removed by pipetting out .

Soluble mixture was washed with

water 2 times to remove non-lipid contaminants, transferred
into scintillation vial containing 5 mL of scintillation
fluid, and radioactivity was determined in Beckman LS 3801
liquid scintillation system .
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Acetyl-CoA and acetylcarnitine were determined
spectrophotometrically by the method (Pearson et al. 1974)
described in detail in appendix 2.

Acetate was determined

by the enzymatic method using acetyl-CoA synthetase (Guynn
and Veech 1975, Bridges et al. 1992) which is described in
detail in appendix 3.

Acetaldehyde was determined by the

enzymatic method of described in detail in appendix 4
(Lundquist 1974).

Acetoacetate was determined by

fluorescent spectrophotometric method of described in detail
in appendix 5 (Mellanby and Williamson 1974).

3-

Hydroxybutyric acid was determined according to the
procedure of Williamson and Mellanby (Williamson and
Mellanby 1974) adapted for fluorescence which is in detail
in appendix 6.
All values shown in the figures and tables are expressed
as group mean ± the standard error of the mean (SEM).

The

Student's t-test (Ott et al. 1987) was used to determine
statistical significance of differences between the means of
treatment groups at p

s 0. 05.

For the time course

experiment, a split-plot-in-time model was used for
analyzing the effects of time and treatment group on ethanol
oxidation.

A residual analysis indicated that using the

natural logarithm transformation of ethanol oxidation data
might be more appropriate than using normal ethanol
oxidation data.

Time, group, and their interaction were

treated as fixed effects, rat nested within group was
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treated as a random effect.

Specific Linear Contrasts were

used to test for differences in each group at the different
time intervals.

For the cell number experiment, a split

plot model was used for analyzing the effects of cell number
(1, 2, 3, 4,
oxidation.

8)

and group (None and L-Carnitine) on ethanol

Group was considered the whole-plot, and cell

number was considered the split-plot.

A residual analysis

indicated that no transformation of the data was necessary,
so ethanol oxidation was analyzed directly.

Cell number,

group, and their interaction were treated as fixed effects,
rat nested within group was treated as a random effect.
Specific Linear Contrasts were used to test for differences
in each group at the different cell numbers.

For the

ethanol concentration experiment, a simple two-way analysis
of variance (without interaction) was used to analyze
ethanol oxidation.

A residual analysis indicated that no

transformation of the data was necessary, so ethanol
oxidation was analyzed directly.

Ethanol concentration was

considered as a fixed effect, and rat was considered a
random effect.
et al. 19�0)

General Linear Mixed Models or GLMM (Blouin
was used to analyze the data (time course,

cell number, and ethanol concentration experiment).

The

GLMM was also used to calculate the Generalized Least Square
Means (GLSM) and their SEM for the fixed effects in the
model, variance components for the random effects, and the
value of the specific contrasts.

Data for all rats were
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used in all three experiments (time course , cell number , and
ethanol concentration) and no data were ignored.
RESULTS

Metabolic integrity of isolated hepatocytes was
determined by studying the time course of ethanol oxidation
(Figure 3. 1) as well as the effect of cell concentration
(Figure 3. 2) and substrate (ethanol) concentration (Figure
3. 3) on ethanol metabolism.
with time for 60 minutes.

Ethanol oxidation was linear
Ethanol oxidation was also linear

with cell numbers up to 8 million cells.

The ethanol

oxidation was increased in proportion to ethanol
concentrations up to 4 mmol. L-1 at which maximum rate was
reached and no increase was observed at higher ethanol
concentrations.

The Lineweaver-Burk plot of the data

(Figure 3. 3 )' provided a Km of 1. 9 mmol. L-1 and Vmax of 11. 1
mmol. L-1 •

Ethanol oxidation in rat hepatocyte with and

without L-carnitine is shown in Figure 3. 4.
ethanol oxidation by rat hepatocytes

The rate of

without carnitine was

24. 69 (nmol. min·1 . million·1 cells) which is 43% higher than
that the rate with L-carnitine (14. 05 nmol. min·1 • million·1
cells).

The time course of ethanol oxidation in hepatocytes

with or without L-carnitine is summarized in Table 3. 1.
There was a significantly decrease in ethanol oxidation by
hepatocytes in the presence of L-carnitine within the first
60 min.

However , the inhibitary effect of carnitine was not
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PXGURE 3 . 1 . Tia• course of ethanol oxidat ion by hepatocytes

1 20

Values are mean ± SEM of 3 different hepatocyte preparations (3
replicates from a single hepatocyte preparation and 1 replicate
from each of the other 2 different hepatocyte preparations).
Incubation mixture consisted of KHB pH 7 . 4 with 2. 5% BSA,
hepatocytes (1 million. mL-1 ) , ethanol (10 mmol. L-1 ) , L-Carnitine
(2 o o µmol.L·1 ) in a total volume of 4 mL.
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PZGURB 3.2. Effect of hepatocyte concentration on ethanol
oxidation
Values are mean ± SEM of 3 different hepatocyte preparations (3
replicates from a single hepatocyte preparation and 1 replicate
from each of the other 2 different hepatocyte preparations).
Incubation mixture consisted of KHB pH 7 . 4 with 2 . 5% BSA,
hepatocytes (1 million. mL·1 ) , ethanol (10 mmol. L.1 ) , L-Carnitine
(200 µmol. L.1 ) in a total volume of 4 mL .
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FIGURE 3 . 3 . Effect of ethanol concentration on ethanol oxidation··
Values are mean ± SEM of 3 different hepatocyte preparations (3
replicates from a single hepatocyte preparation and 1 replicate
from each of the other 2 different hepatocyte preparations).
Incubation mixture consisted of KHB pH 7. 4 with 2. 5% BSA,
hepatocytes (1 million. mL-1 ) , ethanol (10 mmol. L-1 ) , L-Carnitine
(200 µmol. L-1 ) in a total volume of 4 mL.
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PXGURE 3 . 4 . Effect of L-carnitine on ethanol oxidation by
hepatocytes
Values are mean ± SEM of 4 different hepatocyte preparations ( 3
replicates from a single hepatocyte preparation and 1 replicate
from each of the other 3 different hepatocyte preparations ) .
Incubation mixture consisted of KHB pH 7 . 4 with 2 . 5% BSA ,
hepatocytes ( 1 mi l l ion . mL-1 ) , ethanol ( 10 mmol . L-1 ) , L-Carni t ine
( 2 00 µmol . L-1 ) in a total volume of 4 mL .

TABLE 3 . 1

Tia• course of ethanol aetahol isa by hepatocytes 1

Incubation Time (min)
Additions

15

30

60

120

90

Natural Log (µmoles of ethanol metabolized per million� cells)
None

0 . 01 ± 0 . 13•

0 . 65 ± 0 . 14•

1 . 37 ± 0 . 13•

1. 77 ± 0 . 13•

L-Carnitine

-o . 6 ±

O . 20 ± 0. 13b

1. 0 1 ± 0 . 13b

1 . 68

69

26

% Inhibition

59

0 . 13b

±
5

0.

13•

2 . 03 ± 0 . 14•
1 . 94

± 0 . 13•
4

1Values

are mean ± SEM of 5 determinations from 3 different hepatocyte preparations (3
observations/time for one rat and 1 observation/time for 2 other rats).
Values bearing different superscript letters between rows are significantly differenrt
(p s 0. 0 5). Incubation mixture consisted of KHB pH 7. 4 with 2. 5 % BSA, hepatocyte (1
million. mL-1 ) , ethanol (10 mmol . L-1 ) , L-Carnitine (200 µmol . L·1 ) in a total volume
of 4 mL. The precincubation period of 1 0 min preceeded start of reaction by addition of
ethanol and incubation at 37 C for time intervals indicated in the table .

...
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significant beyond 60 min.

As a result the rates of ethanol

oxidation by hepatocytes with L-carnitine was much lower
than the rate without carnitine.

Similarly, the effect of

carnitine on ethanol oxidation by hepatocytes was greater at
lower than at higher cell concentration (Table 3. 2).

The

inhibitory effect of carnitine on ethanol metabolism was
significant at wide range of cell concentrations (0. 25-2
million cells . mL·1 )

.

The effect of carnitine and related compounds on ethanol
oxidation is summarized in Table 3. 3.

Ethanol oxidation was

_significantly reduced by L-carnitine, DL-carnitine, choline,
and L-acetylcarnitine compared to that without any addition.
Choline had almost the same effect as carnitine on ethanol
oxidation and equimolar DL-carnitine showed half the effect
produced by L-carnitine.

Most important, however, was the

effect of acetylcarnitine which produced a much higher
inhibition than did L-carnitine.
The rate of ethanol oxidation in response to different
concentrations (0. 2-40 µmol. �1 ) of L-carnitine and L
acetylcarnitine is shown in Table 3 . 4.

The maximum

inhibitory effect of L-carnitine was at the concentration of
2 o µmol. L·1 •

In contrast, there was an almost identical

inhibitory response by L-acetylcarnitine at the
concentration of o. 2 µmol. L·1 •

Thus, L-acetylcarnitine was

a 100 fold better inhibitor of ethanol metabolism than was
carnitine.

TABLE 3 . 2
Effect of hepatocyte concentration on ethanol aetabol isa1

Hepatocyte Concentration (Millions. 4mL-1 )
Additions

1

2

4

3

8

µ.moles of ethanol metabolized per hour-1
None

1. 7 ± o. 35•

4. 7 ± 0. 35•

7. 0 ± 0. 34•

9 . 8 ± 0 . 35•

17. 3 ± 1. 1 3 •

L-Carnitine

1. 1 ± 0. 35b

2. 8 ± 0. 18b

4. 2 ± 0. 33b

6.0

14. 7 ± 0. 35•

% Inhibition
1

35

40

40

± 0. 35b
39

15

Values are mean ± SEM of 5 determinations from 3 different hepatocyte preparations (3
observations/hepatocytes for one rat and 1 observation/2 the other rats).
Values bearing different superscript letters between rows are significantly different
(p s 0. 05). Incubation mixture consisted of KHB pH 7. 4 with 2. 5 % BSA, hepatocyte (1-8
million. mL4 ) , ethanol (10 mmol. L-1 ) , L-Carnitine (200 µ.mol. L-1 ) in a total volume
of 4 mL. The precincubation period of 10 min preceeded start of reaction by addition of
ethanol and incubation at 37 c for 60 min.
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TABLE 3 . 3

Effect of carnitine and related compounds on ethanol metabolism in hepatocytes
Additions
[ 2 oo µmol. L-1 ]

Ethanol Metabolism
( nmol. min-1 • million-1 cells)

Change
( % )

None

37. 1 ± 1. 17

0

L-Carnitine

27. 3 ± 1. 4 4

-26. 5

DL-Carnitine

31. 4 ± 0. 58

-15. 4

Choline

27. 2 ± 0 . 23

-26. 7

r-Butyrobetaine

42. 8 ± 2. 31

15. 4

�-OH-Butyrate

41. 2 ± 1. 79

11. 0

L-lysine

37. 9 ± 0. 89

2. 2

L-Acetylcarnitine

2 4 . 4 ± 0. 4 6

-34. 2

Palmytylcarnitine

42. 0 ± 1. 79

13. 2

1Values

are mean ± SEM of 3 determinations from 2 different hepatocyte preparations.
Incubation mixture consisted of . KHB pH 7. 4 with 2. 5 % BSA, hepatocyte ( 1 million. mL-1 )
ethanol ( 10 mmol. L-1 ) , L-Carnitine or related compounds ( 200 µmol . L-1 ) in a total
volume of 4 mL. The precincubation period
of 10 min preceeded start of reaction by
°
addition of ethanol and incubation at 37 C for 60 min.

,

"'•

TABLE 3 . 4

Effect of carnitine and acetylcarnitine concentration on ethanol metabolism in hepatocytas 1

concentration (µmol . L· 1 )
Additions
None
L-Carnitine
L-Acetylcarnitine

0

0.2

0.5

1

3

6

12

20

40

Ethanol Oxidation (nmol. min·1• million·1 cells)

49 . 0

27. 5

26 . 0

26 . 0

15. 5

14 . 5

11 . 5

8.0

8.0

8.0

8.0

9.0

11. 5

11. 0

13 . 0

15 . 0

14 . 2

Values are mean of 2 determinations from a single hepatocyte preparation .
Differnent hepatocytes from different rat gave similar results. Incubation mixture
consisted of KHB pH 7 . 4 with 2. 5 % BSA, hepatocyte (1 million. m�1 ), ethanol (10
(200 µmol. L-1 ) in a total volume of 4 mL .
mmol . L-1 ) , L-Carnitine or L-Acetylcarnitine
°
Incubation period was 20 min at 37 C .

1
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The products of ethanol oxidation by hepatocytes with and
without L-carnitine and L-acetylcarnitine is shown in Table
3. 5.

The metabolism of ethanol was determined by the rate

of ethanol disappearance from the medium as well as by the
products of ethanol oxidation.

There was good balance

between ethanol disappearance and the products formed.

The

major (93-95 %) product of ethanol metabolism was CO2 •

The

remaining 4 % were other intermediates of ethanol metabolic
pathway.

Therefore, the major impact of carnitine or

acetylcarnitine inhibition was in terms of CO2 produced.

A

small but quite relevant effect could be appreciated in
concentration of acetaldehyde in presence or absence of
these inhibitors.
DISCUSSION

The carnitine-mediated attenuation of ethanol metabolism
in the intact rat formed the basis for studying the .
mechanism at cellular level.

The rate of ethanol oxidation

by hepatocytes in our study was about 33 nmol. min-1 . million- 1
hepatocytes which is approximately o. 8 µmol. min1 • g- 1 of wet
cell weight or 24 million cells.
range reported

( O . 7-0. 9

These rates are within the

µmol. min-1 . g-1 ) for rat hepatocytes

in presence of no other substrate but only ethanol (Krebs
1975, Crow et al. 1978).

These rates of ethanol oxidation

in isolated hepatocytes are about 70-78% lower than those
(2. 4 - 4. o µmol. min-1 • g-1 of wet weight of liver) observed

TABLE 3 . 5

Effect of carnitina and acatylcarnitine on ethanol aetabolisa aeasured by ethanol
disappearance and product foraation1
None

L-Carnitine

L-Acetylcarnitine

Ethanol Metabolism (nmol . min·1 • million·1 cells)
Ethanol
Disappeared2 :
Product formed3 :
t4co2

14C-Fatty

acids
Acetaldehyde
Acetyl-CoA
Acetylcarnitine
Acetate
Acetoacetate
3-hydroxybutyrate
Recovery ( % )

34. 6 ± 3 . 0

27 . 9 ± 2 . 0

22 . 4 ± 0 . 6

3 0 . 03

24 . 27

18 . 4 4

28 . 0 ± 2 . 1
0 . 27 ± 0 . 05
1 . 5 ± 0 . 06
0 . 13 ± 0 . 01
0 . 13 ± 0 . 02

23 . 2 ± 1 . 6
0 . 12 ± 0 . 06
0 . 6 ± 0 . 03
0 . 1 ± 0 . 01
0 . 2 ± 0 . 01

17 . 6 ± 0 . 1
0 . 11 ± 0 . 09
0 . 3 ± 0 . 06
0 . 1 ± 0 . 01
0 . 27 ± 0 . 01

86 . 8

86 . 9

82 . 3

Values are mean ± SEM of 3 dete�minations from a single hepatocyte preparation .
Incubation mixture consisted of KHB pH 7 . 4 with 2 . 5 % BSA, hepatocyte (1 million . mL-1 )
( 1-14C ] -ethanol (10 mmol . L-1 ) , L-Carnitine or L-Acetylcarnitine
(200 µmol . L· 1 ) in a
°
total volume of 3 mL . Incubation period was 20 min at 37 C .

1
23
•

,
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in intact rat (Sachan 1992, Sachan and Berger 1987, Berger
and Sachan 1991) and in several in vivo studies summarized
by others (Cornell et al. 1977).

The decrease in oxidation

rate of ethanol in isolated hepatocytes is due to loss of
shuttle intermediates during hepatocyte preparation, since
addition of malate and/or lactate restored the rates of
ethanol oxidation in isolated hepatocytes equal to that
found in the intact liver (Cornell 1974,

Krebs et al.

1975).
Ethanol oxidation in isolated hepatocytes was linear with
�ime (Figure 3. 1), cell numbers (Figure 3. 2) and ethanol
concentration (Figure 3. 3).

The data produced a classical

Michaelis-Menten kinetic with a Km = 1. 9 mmol. L-1 and Vmax =
1 1. 1 mmol. L-1•

The

Km

for ethanol is slightly higher than

the Km ( 1. 4 mmol. L-1 ) reported for rat liver ADH-isozyme 3
which is the primary isozyme for ethanol metabolism in rat
(Julia et al. , 1987).

In our hepatocyte preparations,

ethanol oxidation maximized at ethanol concentration of
4mmol. L-1 which is similar to that seen in parenchymal cells
of 24 hour starved female Wistar rats (Grunnet et al. 1973).
Hepatocytes from .fed male Sprague Dawley rats ethanol
metabolized at a constant rate at high ethanol concentration
(Stowell and Crow 1985) which is in concert with our data.
Carnitine inhibited ethanol oxidation in hepatocytes
(Figure 4 and Table 3. 1-3. 2) which is consistent with the
observations in the intact rat (Sachan 1992).

The magnitude
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of inhibition of ethanol metabolism was about 50% in
isolated hepatocytes and about 30% in the intact animal
The

(Sachan and Berger 1986, Mynatt and Sachan 1992).

inhibitory effect was not limited to carnitine alone in
hepatcocytes since equimolar concentations of choline was
equal ly effective in decreasing ethanol oxidation (Table 3).
In the intact rat, choline did not inhibit ethanol
metabolism (Sachan and Berger 1993).

The most important

finding was that acetylcarnitine at concentrations equal to
that of carnitine was far more potent inhibitor of ethanol
metabolism in hepatocytes (Table 3. 3) .

A dose response

study revealed acetylcarnitine to be 100 times more
effective than carnitine alone (Table 3. 4).

While response

to carnitine was preceded by a short lag time, the effect of
acetylcarnitine was immediate.

This is born out by the data

in intact rat where simultaneous administration of carnitine
and ethanol did not attenuate ethanol metabolism and a
minimum period of about 32 hours was essential before effect
of carnitine was seen (Sachan 1992).

A 11-15% stimulation

of ethanol oxidation by butyrobetaine, P-hydroxybutyrate and
palmitylcarnitine is interesting and needs further study.
About 95% of ethanol was oxidized to CO2

and remaining

was found as acetaldehyde, acetyl-CoA, acetylcarnitine and
lipids etc. (Table 3. 5).

Carnitine and acetylcarnitine

reduced these products 20% and 40%, respectively.

since,

acetaldehyde formation was especially decreased by the two
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inhibitors , it suggested inhibition of ADH.
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PART IV
EFFECT OF L-CARNITINE AND L-ACETYLCARNITINE ON
ETHANOL METABOLIZING ENZYMES
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ABSTRACT

Since acetylcarnitine, a metabolite of carnitine, proved
to be a .potent inhibitor of ethanol oxidation in hepatocytes
(Chapter I I I), the main objective of this study was to
determine effects of acetylcarnitine on ethanol metabolizing
enzyme (s).

Because 90% of ethanol oxidation is oxidized via

ADH pathway, this enzyme was targeted for potential
inhibitory effects of acetylcarnitine, carnitine and related
compounds.

The post-microsomal supernatant (PMS) was

prepared from normal male Sprague Dawley rats by
differential centrifugation and used for determination of
ADH activity in the presence or absence of carnitine
derivatives.

It was found that the inhibition of ADH

activity occurred only when NAD concentration was less than
the inhibitor concentration.

As NAD concentration was

decreased, inhibition by acetylcarnitine was significantly
(67%) increased.

Carnitine, choline, and acetylcholine were

very weak inhibitors of ADH.

Inhibition of ADH activity by

acetylcarnitine produced a typical Michaelis-Menten kinetics
(Ki = 135 µmol. I;1 ) and the Lineweaver-Burk plot revealed
that inhibition was of competitive nature.

Binding studies

showed that acetylcarnitine did bind to ADH in a dose
related manner provided NAD: acetylcarnitine ratio was low.
The MEOS activity was not affected by acetylcarnitine or
carnitine.

Both crystalline and crude ADH preparations from

different vertebrate species were also inhibited by
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acetylcarnitine ; however, the yeast enzyme was unaffected .
It is concluded that attenuation of ethanol metabolism is
mediated via the inhibition of ADH by acetylcarnitine under
diminishing concentrations of NAO + .
INTRODUCTION

Ethanol has a wide variety of short- and long-term
effects on human physiology (Hawkins and Kalant 1972) .
Ethanol oxidation occurs primarily in the liver by ADH,
MEOS, and catalase (Lieber, 1991) .

ADH catalyzes the

oxidation of a wide variety of xenobiotic or endogenous
alcohols (Duester 1991, Eklund et al . 1990) .

In addition to

the rate-limiting step in ethanol metabolism (Li 197 7),
human class I ADH catalyzes vitamin A (retinol) oxidation
(Mezey and Holt 197 1), which is the rate-limiting step in
the conversion of retinol to retinoic acid .

Retinoic acid

has been called a hormone like substance because it .
modulates transcription via specific nuclear receptor
(Petkovich et al . 1987, Wahli and Martinez 1991) .
Mammalian ADHs are polymorphic and the isozymes can be
classified based on their function and physicochemical
properties (Julia et al . 1987, Strydom and Vallee 1982) .

It

has been found that isozyme ADH 3 is the enzyme responsible
for ethanol oxidation in rat liver .

It has a Km of 1 . 4

mmol . L·1 for ethanol and Ki of o . 4 µmol . L-1 for pyrazole

(Julia et al . 1987) .
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The role of MEOS in ethanol metabolism has been
controversial .

However, following chronic abuse and high

doses of ethanol, contribution of MEOS to total ethanol
oxidation increases significantly (Lieber, 1987) .

The

peroxidation of ethanol by catalase is limited by the rate
of H202 formation which, under physiological conditions,
would be too low to contribute significantly to total
ethanol oxidation (Li 1977, Lieber et al . 1987, Hawkins and
Kalant 1972) .
Carnitine (J -hydroxy-4N-trimethyl ammonium butyrate) is
an essential cofactor for facilitating fatty acid transport
into the mitochondrial matrix where P-oxidation takes place
(Murthy and Pande 1984) .

It was this role of carnitine that

first prompted investigators to study the possibility that
carnitine might help prevent the ethanol-induced hepatic
steatosis .

In a chronic alcohol feeding trial (36 % calories

as ethanol), carnitine

prevented ethanol-induced

accumulation of total lipids, free and esterified
cholesterol, triglycerides and phospholipids in the liver
and the effect was dose related (Sachan and Rhew, 1983,
Sachan et al . 1984, Rhew and Sachan 1986) .
Carnitine offered this protection by retarding ethanol
clearance due to attenuation of ethanol metabolism under
both acute and chronic conditions of ethanol administration
(Berger and Sachan 1986, Sachan and Berger 1987, Berger and
Sachan 1991, Sachan and Berger 1993) . Further, oxidation of
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orally administered ( 1-14C ] -ethanol to

C02 was significantly

14

reduced 4-12 hours following ethanol administration in the
carnitine supplemented intact rats.

However, in vitro

activities of ADH, MEOS, catalase and acetaldehyde
dehydrogenase were not significantly altered by carnitine
(Mynatt and Sachan 1992, Sachan 1992).

since plasma

concentrations of lactate were increased 2. 5 fold in the
carnitine supplemented rats after ethanol administration,
the explanation was that carnitine attenuated ethanol
oxidation by causing a large shift in the redox state of the
system (Mynatt and Sachan 1992).
In the part III,

we have shown that acetylcarnitine is a

more potent inhibitor of ethanol oxidation in hepatocytes
than was carnitine.

Therefore, the purpose of this study

was to determine potential inhibitory effect of
acetylcarnitine on ADH and MEOS.

The purified (commercial)

and semipurified (PMS, microsomes) enzyme preparations were
used for these studies.
MATERIALS AND METHODS
Chemicals .

14C-acetyl-CoA

was purchased from Moravek

Biochemicals, Inc . (Brea, CA).

L-acetylcarnitine and r

butyrobetaine were obtained from Aldrich Chemical Co.
(Milwaukee, WI).

L-carnitine, DL-carnitine, choline, L

acetylcholine, P-OH-butyrate, L-lysine, gamma
aminobutyrate, Folin & Ciocalteu's phenol reagent, NAD
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(Grade I I I), ADH (Bakers Yeast),

NADPH (Tetrasodium Salt),

Glutathione (reduced form), and palmitylcarnitine were
purchased from Sigma Chemical Co. (St. Louis, MO).

Bovine

serum albumin was obtained from ICN Pharmaceuticals, Inc.
(Cleveland, Ohio).

Ethanol was purchased from Quantum

Chemical Co. (Tuscola, IL).

All other chemicals were from

Baxter Diagnostics Inc. (McGaw Park, IL).
Animals and diets .

The experimental protocol was

approved by committee on Humen Care and Use of Laboratory
Animals.

Male sprague-Dawley rats (Harlan Sprague Dawley

Inc. , Indianapolis, IN) with an average body weight of 200 g
were individually housed in 7" x 10' x 7' stainless steel
wire mesh cages.

Room temperature was maintained at 22 ° C ±

1 ° C and constant relative humidity (52%) with a 12 hour
light-dark cycle.

All specifications of the animal facility

complied with AAALAC regulations.

All animals had free

access to rat chow (Agway Prolab #3000, Syracuse, NY) and
chlorinated city water.
Enzyme preparation .

On the day of experiment, at 8: 30

A . M . , liver of a rat was surgically cannulated and perfused

with cold o . 15 M KCl in O . 0 1 mol. L-1 phosphate buffer, pH
7. 4.

The liver was homogenized in ten volumes of KCl

phosphate buffer, pH 7. 4, in a teflon/glass homogenizer.
The homogenate was centrifuged at 600 x g for 10 minutes at
2 ° C in a Beckman J2-21M induction drive centrifuge (Beckman
Instruments, Inc. , Palo Alto, CA).

The 600 x g supernatant
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(SN) was carefully transferred to another centrifuge tube
and centrifuged at 10, 000 x g for 10 min. The 10, 000 x g SN
was centrifuged at 100, 000 x g for 1 hr. at 4 ° C in a L5-50
Ultracentrifuge.

An aliquot of the PMS was then saved and

used for ADH analysis and 100, 000 x g pellet (microsomes)
was suspended in KHB (pH 7. 4) and used for determination of
MEOS.

Protein concentration in the PMS and microsomes was

determined using Falin & Ciocalteu's phenol reagent (Lowry
et al. 1951).
Determination of ADH activity . ADH activity was estimated
by using a modified procedure of Bergmeyer (Bergmeyer et al.
1974).

Each reaction was performed in a total volume of 3

mL at 37 ° C.

The components and final concentration in the

reaction mixture were sodium pyrophosphate buffer (55

mmol. L·1 ), pH 7. 4, ethanol (20 mmol. L-1 ), NAD + ( o. 2-2 mmol. L·
1 ),

reduced glutathione (1. 1 mmol. L-1 ), semicarbazide (55

mmol. L-1 ), glycine (1. 6 mmol. L-1 ), and enzyme preparation (2-3
mg SN protein).

Whenever necessary deviation in the

concentration of a component was made as it is indicated in
that experiment.

The reaction mixture was preincubated for

3 minutes at 37 ° C in a temperature controlled Beckman Model
34 dual-wavelength spectrophotometer.

The reaction was

initiated with the addition of ethanol and absorbance at 340
nm was recored for at least 3 minutes.
Ethanol oxidation by MEOS . It was determined using a
modified procedure of Lieber (Lieber and Decarli 1970).
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Flasks were divided into three groups ; (a) no inhibitor, (b)
with 200 µmol. �1 L-carnitine or (c) 200 µmol. � 1 L
acetylcarnitine.

Each reaction was performed in a total

volume of 3 mL at 37 ° C in a 25 mL Erlenmeyer flask.

The

components and final concentration in the reaction mixture
were Na2HP04 /KH2P04 buffer (100 mmol. L·1 )
mmol. L-1 )
1

) ,

,

disodium-EDTA (1. 0 mmol. L·1 )

ethanol (10 mmol. L-1 )

microsomal protein) .
last.

,

,

,

pH 7. 4, MgC12

(

5. o

NADPH + H + ( 1 mmol. -

and enzyme preparation (8-10 mg of

The NADPH + H + and ethanol were added

Following NADPH + H + addition the flask was flushed

- with 02+C02 (95: 5) for 20 seconds and the reaction was
started by adding ethanol.

The flask was stoppered with a

serum cap and incubated in a shaking (80 oscillations/ min)
water bath at 37 ° C for 120 min.

A control flask was

prepared for each test flask in which 0. 2 mL 60% HC104 was
added and contents mixed prior to oxygenation and addition
of ethanol and incubation.

The reaction in test flasks was

terminated by inj ecting 0. 2 mL of 60% of HC104 with a
syringe and mixing the contents which were then cooled for
30

min in ice bath.

The reaction mixture was centrifuged at

2000 x g for 10 min and SN were assayed for ethanol
concentration by an enzymatic method (Bernt and Gutmann,
19 74 ) .

Acetylcarni tine binding assay .

( 1-14c]-acetylcarnitine

was synthesized according to the method described in
appendix 7 (Murthy and Pande 1984) .

In a 1. 5 mL micro
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centrifuge tubes (conical bottom with attached closure) the
total volumes of 0. 5 mL contained sodium pyrophospate
buffer, pH 7. 4 (55 mmol. L-1 ), NAD +
reduced glutathione (1. 1 mmol. L-1 )

(O,
,

(

1, 2, and 4 µmol. L-1 ),

1-14C]-acetylcarnitine (2

µmol. L-1 , specific radioactivity 123, 659 dpm. nmo1e·1 or 2061
Bq. nmole) , and horse ADH (0. 17 IU or 100 µg protein) .

The

ratio of ( NAD] : [ 14C-acetylcarnitine] in each tube was
controlled by adding different NAD concentration stated
above resulting in NAD : ( 1-14C]-acetylcarnitine ratio of o,
0. 5, 1, and 2 (see Appendix 7) .

The reaction mixture was

incubated for 5 minutes at 37 ° C in a Dubnoff metabolic
shaking water bath (80 oscillation. min-1 ) .

The reaction

mixture was then transferred to an 30, 000 NMWL Ultrafree-MC
filter unit (Millipore, Bedford, MA) and centrifuged at
maximum speed (15, 000 x g) for 5 min in an Eppendorf
centrifuge, model 5412
Westbury, NY) .

(Sybron/ Brinkmann Instruments,

The residue on membrane sample cup was

transferred to a scintillation vial containing 5 mL
scintillation fluid and the radioactivity was counted in a
Beckman LS 3801 Liquid Scintillation counter.
All values are expressed as group mean ± SEM.

The

student ' s t-test (Ott et al. 1987) was used to determine
significant differences between the means of two groups at
the level of p< 0. 05.

When 2 or more treatments were

compared, an ANOVA was employed and followed with a Duncan ' s
Multiple Range Test (Steel and Torrie 1960) .
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RESULTS

Under the standard conditions of ADH assay , carnitine or
acetylcarnitine did not affect ADH activity (Table 4. 1) .
However , when NAO + concentration was made limiting , ADH
activity was significantly inhibited by acetylcarnitine
which was inversely related to the ratio of
NAD + : acetylcarnitine (Table 4. 2) .

Inhibition by carnitine

and choline was less than 5% compared to 45% by
acetylcarnitine.

The inhibition by acetylcholine ranged

from 2-17% depending on the ratio of NAD: acetylcholine.
The inhibitory effect of acetylcarnitine (22%) was specific
as other compounds inhibited ADH activity little (3-10%) or
none under identical conditions (Table 4. 3) .

Effect of

various acetyl derivatives on ADH activity is summarized in
Table 4. 4.

At equimolar concentration and at NAD: acetyl

derivative ratio of 1: 2 , inhibition of ADH was 28% by
acetylcarnitine , 10% by acetylcholine or acetylCoA , . s% by
ammonium acetate and 5% by sodium acetate.

Carnitine and

choline inhibited ADH activity of 4% and 5% , respectively.
As shown in Table 4. 5 , the oxidation of ethanol by MEOS was
not affected by carnitine or acetylcarnitine under the
standard conditions.
The effects of two concentrations of acetylcarnitine at
various concentrations of NAD + on the activity of ADH is
shown in Table 4. 6 and Figure 4. 1.

Either concentration of

acetylcarnitine produced greater inhibition of ADH at lower
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TABLE 4 . 1

Effect of carnitine and acetylcarnitine on ADH activity•

Inhibitors
( 200 µmol. L·1 ]

ADH Activity2
(nmoles NADH. min·1 • mg·1 )

None

5. 11 ± 0. 05

L-Carnitine

5. 21 ± 0. 03

L-Acetylcarnitine

5. 40 ± 0. 03

1 Conditions:

3 mL of reaction mixture contained sodium
pyrophosphate buffer (55 mmol. L-1 ) , pH 7. 4, NAD (2 mmol.
L-1 ) , reduced glutathione (1. 1 mmol. L-1 ) , enzyme
(mg SN protein) and inhibitor (200 µmol. L-1 ) .
The reaction mixture was preincubated for 3 min at 37 °C
before starting reaction by addition of ethanol (20 mmol.
L-1 ) . Absorbance was monitored at 340 nm for at least 3 min.
2Values are the means ± SEM of 3 determinations.

TABLE 4 . 2

Effect of carnitine, choline, acetylcarnitine, and acetylcholine on ADH activity different
RAD concentration 1
NAO concentration (µmol. L-1 )
Inhibitors

None

25
[ 1: 8 ] 2

100
[ 1: 2 ]

ADH Activity (nmoles NAOH. min·1• mg-1 )
1. 84±0. 012ax
0. 96±0. 005aw
2. 68±0. 005•1

L-Carnitine

0 . 92±0. 017aw
(4. 06)4

Choline

0. 92±0. 0l71w
( 4. 06)

L-Acetylcarnitine

0. 53±0. 00 5bw
(45. 20)

L-Acetylcholine

50
[ 1: 4]

0. 83±0. 012cw
(13. 23)

1. 80±0. 17°
(2. 38)

1. 75±0. 012°
(4. 78)
1. 20±0. 012bx
(40. 49)

1 • 62 ± 0 • 0 23bx
(11. 89)

2. 41±0. 029by
(9. 83)
2. 58±0. 00 5•1
(3. 29)
1. 93±0. 00 5by
(27. 89)
2. 23±0. 00 5by
(16. 71)

200
[ 1: 1 ]
3

4. 78±0. 0 0 5az
4. 69±0. 035az
(1 . 84)

4. 69±0. 0l7az
(1. 84)

4. 43±0. 017bz
(7. 38)
4. 69±0. 012az
(1. 84)

Conditions: 3 mL of reaction mixture contained sodium pyrophosphate buffer (55mmol. Ii1 ) ,
pH 7. 4, NAO (25-200 µmol. L-1 ) , reduced glutathione (1. 1 mol. L-1 ) , enzyme (2-3 mg SN
protein), and inhibitor (200 µmol. Ii1 ) . The reaction mixture was preincubated for 3 min
at 37 ° C before starting reaction by addition of ethanol (20 mmol. �1 ). Absorbance was
monitored at 340 nm for at least 3 min.
2The NAD: inhibitor ratio.
3
Values are the means ± SEM of 3 determinations. Values bearing different superscript
letters (a-c) between rows are significantly different (PS 0. 0 5). Values bearing
different superscript letter (w-z) between columns are significantly different (PS 0. 0 5) .
4
Values in parenthesis indicate percent inhibition with reference to the control.
1

•-..a
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TABLE 4 . 3

Effect of carnitine and related molecules on ADH
activity•
Additions
[ 200 µmol. L-1 ]

ADH Activitt
(nmoles NADH. min· . mg·1 )

Inhibition
(%)

None

2. 47 ± 0. 02•

0

L-Carnitine

2. 24 ± O . O lb

9. 3

DL-Carnitine

3. 39 ± o. 02•

0

Choline

2. 31 ± 0. 01•

6. 5

Choline (pH 7. 0)

2. 31 ± 0. 03•

6. 5

Acetyl-L-Carnitine

1. 92 ± O . O lb

22. 3

r-Butyrobetaine
�-OH-Butyrate
L-Lysine
r-Aminobutyrate

2. 39 ± o. 02•

2. 54 ± o. 02•
2. 54 ± 0. 03•

2. 47 ± o. 02•

3. 2
0
0
0

Conditions: 3 mL of reaction mixture contained sodium
pyrophosphate buffer (55 mmol. L-1 ) , pH 7. 4, NAD (100
µmol. L-1 ) , reduced glutathione (1. 1 mol. L-1 ) , enzyme
(2-3 mg SN protein) and inhibitor (200 µmol. �1 ) . The
reaction mixture was preincubated for 3 min at 37 ° C
before starting reaction by addition of ethanol (20
mmol. L-1 ) . Absorbance was monitored at 340 nm for
at least 3 min.
2
Values are the means ± SEM of 3 determinations.
Values bearing different superscript letters
between rows are significantly different (PS 0. 0 5)
1

TABLE 4 . 4
Effects of acetyl derivatives on ADB activity1

Additions
( 2 00 µmol. L-1 ]

ADH Act ivity2
(nmoles NADH. min-1 • mg-1 )

Inhibition
(%)

NS

3 . 3 3 ± 0. 0 2 •

0

L-Carnitine

3 . 2 1 ± 0. 0 3•

3. 9 6

Choline

3 . 1 6 ± 0. 0 1•

5. 2 5

Acetylcarnitine

2 . 3 7 ± 0. 0 2 b

28. 95

Acetylcholine

2 . 9 8 ± 0. 0 2 b

1 0. 5 3

Amonium Acetate

3 . 0 7 ± 0. 0 1•

7. 9 2

Na-Acetate

3 . 1 5 ± 0. 0 2 •

5. 2 8

Acetyl-Co A

2 . 98

± 0. 0 3 b

1 0. 5 3

•conditions: 3 mL of reaction mixture contained sodium
pyrophosphate buffer (55mmol. L-1 ) , pH 7. 4 , NAO ( 1 0 0
µmol. L-1 ) , reduced glutathion (1.1 mol. L-1 ) , enzyme
( 2 - 3 mg SN protein), and inhibitor ( 2 0 0 µmol. L- 1 ).
The reaction mixture was preincubated for 3 min at 3 7 ° C
before starting reaction by addition of ethanol (2 o mmol. L-1 ) •
Absorbance was monitored at 340 nm for at least 3 min.
2
Values are the means ± SEM of 3 determinations.
Values bearing different superscript letters between rows are
significantly different (P� 0. 0 5 )
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TABLE 4 . 5

Effect of carnitine and acetylcarnitine on ethanol
oxidation hy rat liver microsomes (MEOS ) 1
Additions
( 200 µmol. L-1 ]

Ethanol oxidation2
(mmol. L-1 • h-1 • g·1 microsomal protein)

None

30. 55

±

0. 98

L-Carnitine

3 1 . 68

±

1 . 14

L-Acetylcarnitine

31. 84

±

1. 50

1 Condisions:

3 mL of reaction mixture contained sodium
potassium phosphate buffer (100 mmol. L-1 ) , pH 7. 4,
MgCl 2 ( 5. 0 mmol . L-1 ) , disodium-EDTA ( 1 mmo l . L-1 ) , NADPH
+ H + (1. 0 mmol. L-1 ) , enzyme (8-10 mg microsomal
protein), and ethanol (10 mmol. L-1 ) . Reaction mixture
was incubated for 120 min. at 37 °C in methods.
2Values are the means ± SEM of triplicate from 3
different rats.

TABLE 4 . 6
Inhibition of ADR activity at different concentrations of NAD and L-acetylcarnitine1

Inhibitor

NAD Concentration (µmol. L-1 )
25

50

100

200

400

1000

2000

ADH Activity (nmoles NADH. min·1 • mg-1 ) 2
1. 39

1. 93

2. 93

4. 32

4. 77

5. 10

5. 49

L-Acetylcarnitine
[ 100 µmol. L-1 ]

0. 67
(51. 8)3

1. 61
(16. 5)

2. 45
(16. 3)

4. 23
(2. 1)

4. 77
(0)

5. 10
(0)

5. 49
(0)

L-Acetylcarnitine
[ 200 µmol. L-1 ]

0. 46
(64. 7)

1. 12
(41. 9)

1. 93
(34. 1)

2. 94
(31. 9)

4. 00
(16. 1)

None

5. 10
(0)

5. 49
(0)

Conditions: 3 mL of reaction mixture contained sodium pyrophosphate buffer (55mmol. L'1 ) ,
pH 7. 4, NAD (25-2000 µmol. L-1 ) , reduced glutathione (1. 1 mol. L-1 ) , enzyme (2-3 mg SN
protein), and inhibitor (100 and 200 µmol. L'1 ) . The reaction mixture was preincubated for
3 min at 37 ° C before starting reaction by addition of ethanol (20 mmol. L'1 ) . Absorbance
was monitored at 340 nm for at least 3 min.
2
Values are the means of 2 determinations.
3
Values in parenthesis indicate percent inhibition with reference to the control.
1
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than at higher concentrations of NAO + .

At a given

concentration of NAD + , higher concentration (200 µmol. L-1 ) of
acetylcarnitine was proportionally more inhibitory than
lower concentration (100 µmol. �1 ).

The plot of reaction

velocity and the concentration of NAD (co-substrate)
resulted in 3 separate hyperbolic curves which obeyed
classical Michaelis-Menten kinetics (Figure 4. 1).

A

Lineweaver-Burk plot of this data (Figure 4. 2) produced a
definite shift in the Km without affecting Vmax which is the
characteristic of competitive inhibition (Table 4. 7).

The

Ki at 100 µmol. �1 and 200 µmol. �1 of acetylcarnitine were
184. 5 and 135. 1 µmol. �1 , respectively.
In order to access the site of acetylcarnitine
interaction, NAD + and acetylcarnitine were preincubated with
ADH and reaction velocity was measured (Table 4. 8).

When

enzyme was preincubated with acetylcarnitine alone or with
acetylcarnitine plus NAD + , the inhibition was essentially
identical, however, when ADH was preincubated with NAD +
first the inhibition by acetylcarnitine was decreased .

This

suggested that interactions were at the level of enzyme and
not NAO.

A more direct assessment was made by studying the

binding ( 1-uC ] -acetylcarnitine to ADH at different ratio of
NAD: ( 1- 14C ] -acetylcarnitine (Table 4. 9).
1 4C ] -acetylcarnitine

The binding of [ l-

to ADH was decreased as the ratio of

NAD: acetylcarnitine was increased.
The effect of carnitine and acetylcarnitine on the

1 . 20 -
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TABLE 4 . 7

Kinetic paraaeters for ADH activity at varying
concentrations of acetylcarnitine1
Additions
None

Km

(µmol . L-1 )

Vmax
(µmol . L-1 )

Ki
(µmol . L-1 )

87 . 64

5 . 71

Acetyl-L-Carnitine
( 100 µmol . L-1 )

113 . 02

5 . 71

184 . 52

Acetyl-L-Carnitine
( 200 µmol . L-1 )

217 . 00

5 . 71

135 . 09

Kinetic parameters were calculated from the values
in Table 4 . 5 using computer program (Enzfitter) .

1

TABLE 4 . 8

Znhibition of ADR activity by carnitine , choline , acetylcarnitine , and
acetylcholine under different experiaental condition
Inhibitor: NAO Cone.
[ 2 00: 100 µmol. L-1 ]

Experimental Condition 1
B

A

C

AOH Activity (nmoles NAOH. min. ·1 . mg·1 ) 2
None
L-Carnitine
L-Acetylcarnitine
Choline
L-Acetylcholine

3. 33

2. 67

3. 20
(3. 96)

( 1 . 64 )

1. 93
(27. 87)

2. 37
(28. 95)

2. 19
(18. 05)

2 . 59
(3. 29)

' 3. 16
(5. 25)

( 1 . 64 )

2. 23
(16. 71)

2. 98
(10. 53)

(9. 83)

2. 67
2 . 41

(9 . 83 )

3

2. 63

2. 63
2 . 41

Experimental Conditions were as described in table 4 except the following
A: NAO + inhibitor preincubated for 3 min. prior to ethanol addition
B: Inhibitor preincubated for 3 min. prior to NAO + ethanol addition
C: NAO preincubated for J · min. prior to inhibitor + ethanol addition
2
Values are the means of 2 determinations.
3values in parenthesis indicate percent inhibition with reference to the
control.
1

CD
w

TABLE 4.9

Binding of (1-"c] -acetylcarnitine to horse alcohol dehydrogenase at
different ratio of [HAD ] : [1-14C ] -acetylcarnitine ] 1,2
NAD: [ l- 14C ]
Acetylcarnitine· 1

[

C ] DPM/mg Enzyme
protein

14

% Binding

0

5 0 5 1 ± 2 5 2•

5 . 1 ± 0 . 2 3•

0.5

3 8 4 5 ± 2 4 0b

3 . 9 ± 0 . 2 3b

1

3499 ± 214c

3. 5 ± 0. 17c

2

17 7 2 ± 1 0 2 d

1 . 7 ± o. 0 5 d

1 Conditions:

( 5 5 mmol. L- 1 )

0 . 5 mL of reaction mixture contained sodium pyrophosphate buffer
1
1
, pH 7. 4, NAO ( 0 - 2 nmol. L- ) , reduced glutathione ( 1 . 1 mmol. L- ) ,

nmol. L-1 ) , and horse ADH ( 0 . 1 7 µmo1. L-1 or mg
protein). Reaction mixture was incubated for 5 min. at 3 7 °c , filtered through
millipore filter by centrifugation, and counted 14C in the filter.
2The values are means ± SEM of 3 determinations.
Values bearing different superscript letters between rows are significantly
different (PS 0 . 0 5 )
[ 1 - 14C ] -Acetylcarnitine ( 1

•

GO
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activity of ADH derived from different species is shown in
Table 4. 10.

Neither carnitine nor acetylcarnitine inhibited

the yeast ADH activity.

However, the activities of ADH from

horse, rat, guinea pig, mouse and broilers were
significantly inhibited by acetylcarnitine.
DISCUSSION

The analysis of the products of ethanol oxidation by
hepatocytes (Table 3. 5) revealed 80% inhibition of
acetaldehyde formation in presence of acetylcarnitine
suggesting that the site of inhibition must be at the
enzymatic level.

since ADH is the main enzyme of ethanol

oxidation, it was considered to be the target enzyme for
studying the effect of carnitine, acetylcarnitine, and
related compounds.

The results showed that acetylcarnitine

inhibited ADH only when the ratio of NAD: acetylcarnitine was
low.

The inhibition was minimum (7%) at the ratio of 1: 1

and maximum (45%) at ratio of 1: 8 (Table 4. 2).

When this

ratio was higher than 1: 1, there was no effect of
acetylcarnitine on ADH (Table 4. 1).

On the other hand, at

any ratio of NAD: carnitine, thheinhibition of ADH was no
more than 10%.

In previous studies (Mynatt and Sachan 1992)

also, carnitine produced little or no inhibition of ADH.
The specificity of ADH inhibition by acetylcarnitine was
determined using structurally related compounds e. g. choline
and acetylcholine or carnitine precursors namely, r-

TABLE 4 . 10
Inhibition of ADH from different species by carnitine and acetylcarnitine 1

Inhibitor
None

Species

L-Carnitine

L-Acetylcarnitine

ADH Activity (nmoles NADH . min-1 • mg-1 ) 2
3 6 . 18

±

0 . 2• ( 0 ) 5

0 . 0 1•

0 . 48

±

0 . 01•

±

0 . 2•

3 . 20

±

7 . 33

±

0 . 5•

6 . 58

Mouse4

6 . 49

±

0 . 0 5•

Broilers4

4 . 06

±

0 . 2•

Yeast3

3 6 . 18

±

0 . 1•

Horse3

0 . 53

±

Rat4

3 . 33

Guinea Pig4

3 6 • 18

±

0 • 1• ( 0 )

0 . 38

±

O . O lb ( 2 7 . 3 )

0 . 2• ( 3 . 3 )

2 . 36

±

O . lb ( 2 7 . 9 )

±

0 . 4· ( 8 . 0 )

5 . 37

±

0 . 4b ( 2 6 . 8 )

6 . 02

±

0 . 1• ( 7 . 3 )

5 . 03

±

0 . 2b ( 2 2 . 5 )

3 . 85

±

0 . 2• ( 5 . 2 )

3 . 01

±

0 . 3b ( 15 . 3 )

(9 . 2 )

1 Conditions:

3 mL of reaction mixture contained sodium pyrophosphate buffer
mmol . L-1 ) , pH 7 . 4 , NAO ( 1 0 0 µmol . L-1 ) , reduced glutathione ( 1 . 1 mol . L-1 ) ,
enzyme ( 2 - 3 mg SN protein), and inhibitor ( 2 0 0 µmol . L-1 ) . The reaction mixture was
preincubated for 3 min at 3 7 ° C before starting reaction by addition of ethanol .
Absorbance was monitored at 3 4 0 nm for at least 3 min .
2
Values are the means ± SEM of triplicate determinations . Values bearing different
superscript letters between columns are significantly different (P� 0 . 0 5 )
3The ADH was purchased from ·the Sigma Chemical co .
4
The ADH was prepared by differential centrifugation and 1 0 0 , 0 0 0 x g supernatant was
used .
5values in parenthesis indicate percent inhibition with reference to the control .
CD
(55
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butyrobetaine and lysine .

Among these compounds , only

choline , acetylcholine , and butyrobetaine inhibited ADH
approximately 5% , 14% , and 3% , respectively (Table 4. 2-4. 3) .
Because of relatively high degree of inhibition by
acetylcarnitine and acetylcholine compare to carnitine and
choline , it was necessary to examine effect of acetyl
moiety .

Acetyl group by itself was not able to inhibit ADH

any more than choline or carnitine , however , acetyl-CoA was
as effective as acetylcholine , both of which at equimolar
concentration produced only about 30% of the inhibition
caused by acetylcarnitine (Table 4 . 4 ) .

Therefore , it is

concluded that the inhibition of ADH by acetylcarnitine is
specific and can not be matched by the related compounds we
studied .

These result provide explanation for the lack of

significant (10%) inhibition by choline (Sachan and Berger
1993) and the requirement of a pretreatment period with
carnitine for its inhibition of ethanol metabolism in the
intact rat (Sachan 1992) .

In the intact system , it would be

difficult to maintain a low ratio of NAD: acetylcarnitine
because NAD + is being constantly regenerated and
acetylcarnitine is being excreted in urine .

However , the

picture may be quite different in the chronic alcoholic
condition .
There are a large number of molecules which have some
degree of inhibitory effect on ADH (Table AS . l) .

Among

these Pyrazol and its 4-substituted derivatives are most
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potent and widely studied compound with regard to ADH
inhibition (Goldberg and Rydberg 1969 , Oanielesson et al .
199 2 ) .

The inhibition varies with the isozyme involved e . g .

rat ADH 3 has a Ki = 0 . 4 µM , ADH 1 ki = 0 . 5 6 µM but AOH 2 is
insens itive to pyrazol ( Julia et al . 198 6 ) .

Pyrazol and its

analogues are competitive inhibitors of ADH ( Goldberg and
Rydberg 19 69 ) which is brought about by formation of an
extremely tight ADH-NAD + and pyrazol ternary complex
( Khalifah and Sutherland 197 9 ) .

The precise mode of binding

of pyraz oles has not been elucidated .

However , it is

_proposed that heterocyclic ring of pyrazole forms a bridge
through its two nitrogen atoms and the catalytic z inc atom
and C-4 of the nicotinamide moiety of NAO (Branden et al .
197 5 ) .

The mechanism of acetylcarnitine inhibition may be

similar to that of pyra zole since it does have quaternary
nitrogen .
Inhibitor molecules bind to enzyme protein either . at the
coenzyme binding site or at the substrate binding site .
Three main coenzyme binding sites where inhibitors are known
to bind are 1 ) the adenos ine binding cleft for aromatic
molecules , 2 ) the anion binding site where the pyrophosphate
group of the coenzyme binds , and 3 ) the nicotinamide binding
region (Branden et al . 197 5 ) .

Acetylcarnitine appears to

bind to AOH at the site of NAO binding since NAO inhibited
acetylcarnitine binding to AOH in a dose dependent manner .
When the ratio of NAD : acetylcarnitine was increased from o
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to 2, binding of ( 1- 14c-acetylcarnitine to ADH decreased 67%
(Table 4. 10).

The affinity of ADH for binding is greater

for NAD than acetylcarnitine as indicated by preincubation
experiments shown in Table 4. 9.

However, these experiments

do not inhibitory rule out the possibility of alteration of
NAD configuration by acetylcarnitine.
Acetylcarnitine-NAD + interactions inhibited ADH
preparations from broiler chicken, guinea pig, horse, mouse,
rat but not the enzyme from yeast (Table 4. 11).

The

specificity may be related to different isozymes of the
species (Julia et al. 1987).

The ADH is not a single enzyme

but a system consisting of many isozymes which are species
specific to a certain degree.

Yeast and mammalian ADH

differ in substrate specificity and rate of catalytic
activity (Branden et al. 1975).

Human and rodent ADH exists

as a heterogeneous group of isoenzymes that can be placed
into three categories based upon structural and functional
distinctions (Strydom and Vallee 1982).

There are clear

analogies between human ADH classes and rat ADH isoenzymes.
There is approximately 82% sequence homology among subunits
of human and rat liver ADH (Julia et al. 1987).

The kinetic

and molecular properties of rat ADH 3 are similar to those
of human class I isoenzymes.

It is well known that ethanol

is the substrate for classical human class I ADH (Li 1977)
and rat ADH 3 (Julia et al. 1987) isoenzyme.

Both human

class I and rat ADH 3 are mainly localized in liver and rat
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enzyme exhibits a Km of 1. 4 mmol. L-1 for ethanol and it is
strongly inhibited by pyrazole, ki = o. 4 µmol. L-1•
This data provides molecular explanation for carnitine
mediated attenuation of ethanol metabolism in the intact rat
(Sachan and Berger 1987, Mynatt and Sachan 1992), mouse
(Sachan 1992) and broiler chicken (Smith et al. 1993).
These similarities and differences among species must be
born in mind in extrapolation of rat data to humans.
LITERATURE CITED

Berger, R. & Sachan, D. s . (1986) Elevation of blood-ethanol
concentrations in carnitine-supplemented rats. Nut. Rep.
Int. 34: 153-157.

Berger, R. & Sachan, D. s . (1991) Effects of supplementary
levels of L-carnitine on blood and urinary carnitines and
on the portal-systemic blood-ethanol concentrations in the
rat. J. Nutr. Biochem. 2: 382-386.

Bergmeyer, H. u . , Gawehn, K. & Grassal, M. (1974) Enzymes as
biological reagent. In: Methods of enzymatic analysis.
(Bergmeyer, H. u . , ed. ) vol. 1 pp. 428-430. Verlag Chemie
Int. Deerfild Beach, FL.

Branden, c . I. , Jornvall, H. , Eklund, H. & Furugren, B.
(1975) Alcohol dehydrogenase. In: The enzymes. (Boyer, P.
D. , ed. ), vol. 3 pp. 103-189. Academic Press, New york.

Duester, G. (1991) Human liver alcohol dehydrogenase gene
expression: retinoic acid homeostasis and fetal alcohol
syndrom, pp 375-402. In Watson ed. , Drug and alcohol abuse
reviews, vol. 2. Liver pathology. Humana Press, Clifton,
N. J.

Danielsson, o . , Eklund, H. & Jornvall, H. (1992) The major
piscine liver alcohol dehydrogenase has class-mixed
properties in relation to mammalian alcohol dehydrogenases
of classes I and I I I. Biochemistry 31: 3751-3759.

91

Eklund, H. , Muller-Wille, P. , Horjales, E. , Futer, o . ,
Holmquist, B. , Vallee, B. L. , Hoog, J. o . , Kaiser, R. &
Jornvall, H. (1990) Comparison of three classes of human
liver alcohol dehydrogenase. Emphasis on different
substrate binding pockets. Eur. J. Biochem. 193: 303-310.

Goldberg, L. & Ryberg, u. (1969) Inhibition of ethanol
metabolism in vivo by administration of pyrazole. Biochem.
Pharmacol. 18: 1749-1762.
Hawkins, R. D. & Kalant, H. (1972) The metabolism of ethanol
and its metabolic effects. Pharm. Rev. 24: 67-157.
Julia, P. , Farres, J. & Pares, X. (1987) Characterization of
three isoenzymes of rat alcohol dehydrogenase. Eur. J.
Biochem. 162: 179-189.
Julia, P. , Farres, J. & Pares, X. (1986) Ocular alcohol
dehydrogenase in the rat: Regional distribution and
kinetices of the ADH 1 isozyme with retinol and retinal.
Exp. Eye res. 42: 305-314.
Li, T. K. (197 7) Enzymology of human alcohol metabolism. In:
Advances in Enzymology. (Meister, A. ed. ) 45: 427 -483,
John Wiley and Sons, New York.
Lieber, c . s . , Baraona, E. , Leo, M. A. & Garro, A. (1987)
Metabolism and metabolic effect of ethanol, including
interaction with drugs, carcinoges, and nutrition. Mut.
Res. 186: 201-233.

Lieber, C. s . & Decarli, L. M. (1970) Hepatic microsomal
ethanol-oxidazing system. J. Biol. Chem. 245: 250 5-2512.

Lieber, c . s . (1991) Alcohol, Liver, and Nutrition. J. Am.
College of Nutrition 10: 602-632.
Lowry, o . , Rosebrough, N. Farr, A. & Randall, R. (1951)
Protein measurement with the folin phenol reagent. J.
Biol. Chem. 237: 587-595.

Mezey, E. & Holt, P. R. (1971) The inhibitory effect of
ethanol on retinol oxidation by human liver and cattle
retina. Exp. Mol. Pathol. 15: 148-156.

Murthy, M. S. R. & Pande, s . V. (1984) Mechanism of carnitine
acylcarnitine translocase catalyzed import of
acycarnitines into mitochondria. J. Biol. Chem. 259: 90829089.

Mynatt, R. L. (1992) altered redox state as a basis for
carnitine-mediated attenuation of ethanol oxidation in the

92
rat. Biochemical Archives 8: 349-353.

Ott, L. , Larson, R. F. & Mendenhall, w. (1987) Statistics: a
tool for the social sciences. Vol. 4 pp. 313-315 PWS
Publishers, Boston, MA.
Petkovich, M. , Brand, N. J . , Krust, A. & Chambon, P. (1987)
A human retinoic acid receptor which belongs to the family
of nuclear receptors. Nature (London) 330: 444-450.

Rhew, T. H. & Sachan, D. s . (1986) Dose-dependent lipotropic
effect of carnitine in chronic alcoholic rats. J. Nutr.
116: 2263-2269.
Sachan, D. s . (1992) Carnitine-mediated attenuation of
ethanol metabolism. In: "Current concepts un carnitine
research" (Carter, A. L. ed. ), pp. 79-91, CRC Press, Boca
Raton, FL.

Sachan, D. s . & Berger, R. (1993) Specificity of carnitine
in attenuation of ethanol metabolism in the rat.
Biochemical Archives 9: 141-146.

Sachan, D. s . & Berger, R. (1987) Attenuation of ethanol
metabolism by supplementary carnitine in rats. Acohol 4:
31-35.

Sachan, D. s . & Rhew, T. H. (1983) Lipotropic effect of
carnitine on alcohol-induced hepatic steatosis. Nutrition
Reports International 27: 1221-1226.

Sachan, D. s . , Rhew, T. H. & Ruark, R. A. (1984)
Ameliorating effect of carnitine and its precursors on
acohol-induced fatty liver. Am. J . Clin. Nutri. 39: 738744.

Smith, M. o . , Cha, Y. s . & Sachan, D. s . (1993) Alcohol
metabolism in broilers: Effect of L-carnitine. submitted
to J . Poultry Sci.
Steel, R. G. D. and Torrie, J. H. (196 0) Principles and
procedures of statistics. pp. 67-87. McGraw Hill Bood Co.
New York, NY.
Strydom, P. J . & Vallee, B. L. (1982) Characterization of
human alcohol dehydrogenase isoenzymes by high performace
liquid chromatography peptide mapping. Anal. Biochem. 123:
422-429 .

Wahli, w. & Martinez, E. (1991) Superfamily of steroid
nuclear receptors: positive and negative regulators of
gene expression. FASEB J . 5: 2243-2249.

APPBBDICES

APPENDIX 1

BEPATOCYTE PREPARATION
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A . Preparation of solutions for perfusion
Table A 1 . 1 .
compos ition of buffers used for collagenase perfus ion
Chemicals
(g)

Ca + + -free
perfusion
buffer (L)

Collagenase
buffer (L)

suspension
buffer (L)

NaCl
KCl
CaC12
MgC12 • 6H20
KH2P04
MgS04
Na2S04
NaHC03
HEPES
TES
Tricine
1 M NaOH
Collagenase
pH

8.3
0. 5

0 . 39
0 . 05
0 . 529

0.4
0 . 04
0 . 0136
0 . 013
0 . 05

9
0 . 46
0 . 37
0 . 21
0 . 38

0 . 01
2. 4

2.4

5.5

6.6
0 . 05
7.6

7.4

KrebsHenseleit
buffer(L)

2 . 73

0 . 72
0 . 69
0 . 65
5 . 25

7.4

7.6

B . Preparation of apparatus
We used the perfusion apparatus similar to that described
by Seglen (Seglen 197 6) and shown in Figure A 1 . 1 .
1 . It ' s most important unit is the water-jacketed
coiled tube (1), which maintains the perfusate
temperature at 37 ° C (2 x 4 mm glass tube in 22 to 24
coil ; coil diameter 30 mm ; coil length 100 mm) .
2 . A combined filter unit and bubble trap (2) is made
of a short piece of silicone rubber tubing with

a

rubber stopper in each end ; stainless-steel
cannulas are used to pierce the stopper .

A cotton plug

+-{D

FIGURE A · 1 . 1 Experimental apparatus for liver perfusion
(Seglen 1976)

'°

0\
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is used as a filter ; the cotton is carefully packed at
the portal, end of the fluid-filled filter unit, taking
care to avoid the trapping of bubbles within the cotton.
3. From the other end of the coiled tube a long
stretch (90

Cm)

of 2 x 4 mm silicone rubber tubing

leads through the pump (3) to the buffer reservoir.
4. The coiled tube is fixed with a clamp onto a
flexible lamp holder.

The whole coiled

tube

filter-cannula assembly can thus be moved freely in all
directions, which facilitates exact positioning of the
portal cannula and easy transfer of the cannulated liver
from the body to the liver dish.
5. The latter is a flat glass bottle (diameter 80 mm)
with a conical outlet (4) ; the isolated liver is
placed on a nylon net in the bottom of the dish.
6. When ca + + -buffer is recirculated before perfusion,
the oxygenation (5) is provided to

sufficient

surface area for complete oxygenation of the
perfusate.

c . surgical procedure and perfusion

1. The rat was anesthetized by Metofane (Pitman-Moore, Inc.
Mundelein, IL) in jar placed a hood , it was carefully
transferred to the operating tray.
2. The rat was placed on its back on the operating tray
with its neck stright.

The abdomen was opened by a v-
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incision, begining at lower abdomen and extending

to the back near last left ribs.

The intestines were

displaced to the left side of the abdominal cavity (right
of operator) so that portal vein and posterior vena carva
were in right.
3. A loose ligature was placed around the portal vein
at about 1 em poster to entry point in liver (Fig. A
1. 1). The portal cannula was then placed

adjacent to the

portal vein.
4. The perfusate flow (ca + + -free perfusion buffer) is
started at a rate of 30 mL per min.

The oxygenator

cylinder is used as a reservoir for the perfusion buffer
(about 500 mL), which was maintained at 37 ° C and
saturated with oxygen.
5. A deep cut was made in the posterior vena cava and using
a fine scissors a small (hafeway through wall) cut was
rapidly made in the petal vein a few mm inferior . to
ligature (Fig. A 1. 1: upper arrow).
6. The portal cannula was rapidly inserted into the vein
through the cut and pushed up towards lower so that it
lies about portal 2-4 mm inside the ligature.

The

ligature was securely tied and secured in place with an
extra knot.
7. The perfusate flow was increased to 50 mL per
minute.

The first 2-3 minutes of preperfusion was

allowed while the liver remained intact in situ.
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8. While preperfusion is continued, the liver was removed
from the carcass by cutting all attachments including the
vascular and biliary supply distal to the ligature (one
cut), both ends of the vena cava as close to the liver as
possible, and the thin, clear ligaments to the intestines
and the abdominal wall.

Care was exercised to avoid

twisting of the hepatic lobes, cutting into the liver
tissue, and rupture of the liver capsule due to
stretching of the ligaments.
9. The liver is transferred to the liver perfusion dish (
temporarily placed on top of a 250 mL beaker) and laid
flat in a normal position similar to them in situ
position.

A good perfusion of liver should allow

rapid perfusate afflux with no swelling, and the
whole liver should have a uniform, light-tan color.
10. When 500 mL of the ca + + -free perfusion buffer in the
oxygenator-reservoir has been used about 10 min, - the flow
pump was momentarily stopped, and reservoir was changed
from ca + + -free buffer to collagenase buffer.
11. The perfusate flow was immediately reswitched at its
maximal rate (50 mL. min), and the liver dish was placed
on top of the collagenase buffer beaker.
12. The liver is perfused with recirculating
collagenase buffer 50 mL. min for 7-10 minutes ; during
this time it swells to more than twice its original
size.
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13. The liver is then transferred to a watch glass
containing 5 mL of KHB with 2. 5% BSA.

The liver is

held up with forceps (portal region) and gently shaken,
the cells are liberated from the liver connective and
vascular

stroma by careful raking with a

stainless

steel fork.
D . Cell collection and viability test
1.

The cell suspension was distributed in a 10 mL KHB with
2. 5% BSA and centrifuged in a Beckman TJ-6R tabletop
centrifuge at 50 x g for 3 min at 25 ° C.

2.

The supernatant and lose pellet was discared and heavy
cells fluid was resuspened in 10 mL of KHB with 2. 5% BSA
and centrifuged as above.

3.

The final packaged cells were suspened in KHB with 2. 5%
BSA and kept at room temperature until the experiment.

4.

Cell suspension was diluted 1: 10 and 100 µL of it was
treated with 0. 6% trypan blue (1: 1).

The cells .were

counted in a hemacytometer, 4 outer squares, using an
Olympus T041 microscope.

Cell numbers was calculated as

follow: Cells/mL = # of counted cell x DF / 4 and % of
viability was determined (should be upper 90 %).
References :

1. Seglen, P. o . (1976) Preparation of isolated rat
liver cells. Meth. in Cell Ciol. 13: 29-83.

2. Horne, D. W. , Briggs, w . T. & Wagner, c . (1976) A
functional, active transport system for methotrexate in
freshly isolated hepatocytes. Biochemical and
Biophysical research communications 68: 70-76.

APPENDIX 2
ACBTYLCARRITINE AND ACBTYL-CoA DETERMINATION
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Acetylcarnitine was determined spectrophotometrically by
the method of Pearson et al. (Pearson et al. 1974) .
Principle
CAT

(1) Acetylcarnitine + CoASH<=====> carnitine + Ac-CoA
citrate

(2) Ac-CoA + Oxaloacetate ----------> Citrate + CoASH
syntbue

MDH

(3) Malate + NAD + <======> Oxaloacetate + NADH + H +
The acetyl-CoA formed in reaction (1) reacts with
oxaloacetate in the presence of citrate synthase to give
citrate ( eqn. (2) ] ; CoASH is regenerated. The consumption of
oxaloacetate leads to disturbance of the equilibrium of the
malate dehydrogenase (MDH) reaction (3) with consequent
reduction of NAD. The increase in the NADH concentration, as
meassured by the extinction at 340 nm, is the unit of
measurement.
Equipment

Spectrophotometer for measurements at 340 nm.
Reagents

1. 1 M Potassium malate: Dissolve 13. 4 g L-malic acid in
water , adj ust to pH 7. 5 with 5 N KOH , and make vol. to
100 mL with distilled water.
2. 10 mM P-Nicotinamide-adenine dinucleotide: Dissolve 23. 1

10 3

mg NAO in approx. 1 mL distilled water, add 0. 045 mL lN
KOH, and dilute to 3 mL with distilled water.
3. 10 mM Coenzyme A: Dissolve 10 mg CoA in 1 mL distilled
water.
4. Malate dehydrogenase, MOH (1 mg protein. mI:1 ) : Dilute
stock suspension to get desired concnetration with 3. 2 M
ammoniumsulphate solution (pH=6. 0)
5. citrate synthase, cs (1 mg protein. mI:1 ) : Dilute stock
suspension to ge desired concentration with 3. 2 M
ammonium sulphate solu�ion (pH=6. 0).
6. 1 M Tris buffer (pH 7. 8): Dissolve 12. 1 g tris in 65 mL
1 N HCl, and make up to 100 mL with distilled water.
7. 50 mM Ethylenediaminetetra-acetate, EDTA: Dissolve 0. 46
g EDTA-Na2H2. 2H20 in 20 mL distilled water, adjust pH to
8 with 1 N KOH, and make up to 25 mL with water.
8. carnitine acetyltransferase, CAT (l mg protein. mL-1 ) :
Dissolve 1 mL suspention in 4 mL potassium phosphate
buffer.
9. 0. 5 M Phosphate buffer (pH 7. 5): Dissolve 6. 8 g KH2P04 in
approx. 70 ml of water, adjust to pH 7. 5 with approx.
2. 2 mL 5 N KOH, and make up to 100 mL with distilled
water.
10. 50 mM Perchloric acid: Dilute 4. 2 mL 70% HC104 to 100 mL
with distilled water.
11. 30 mM Acetylcarnitine:
12. 30 mM Acetyl-CoA:
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Procedure
A standard curve was prepared by adding

o , 10, 20, 40,

60, 80 and 100 µl (Table A 2. 1) of acetylcarnitine standard
(30

mM)

to tubes containing 100 µl 10% BSA, 300 µl of 3. 0 M

HC104 and double distilled water to a total volume of 1. 65
mL.

The tubes were vortexed vigorously for 30 sec and

allowed to sit in an ice water bath for 5 min, vortexed
again and centrifuged for 10 min at 1500 x g at 2 ° C.
1. 0 mL of the supernatant was removed and added to
another conical tube on ice. 200 µl of 3 M KHC03 was added,
vortexed and allowed to sit for 15 min, then centrifuged for
The supernatant was then poured

10 min at 1500 x g at 2 ° C.
off into another tube on ice.

A 100 µl aliquot of the neutralized standard or samples
(cell supernatant) were added to 1. 86 mL of reaction mixture
(1) in a 3 mL polystyrene disposable cuvette (Baxter
Scientific Products, Atlanta, GA) and mixed by inversion and
read extinction (Ei ).

MDH suspention (2) was pipetted into

the cuvette, mixed, waited until equilibrium was reached,
and read extinction

( :Ei ) •

cs suspension (3) was

added, mixed, waited until reaction stoped, and read
extinction (E3 )

.

Acetyl-CoA in the sample was reacted.

CAT

solution (4) was mixed, waited until reaction stoped, and
read extinction (E3 )

.

Acetylcarnitine was reacted in this

reaction (5-15 min).
@ E1 = E2 - E1

@ :Ei = E3 -

Ei

@ E3 = E4 - E3
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Table A 2 . 1
Reaction mixture and summary of procedure
Reagent

volume (ml)

(1) 1 M Tris buffer
L-Malate solution
EOTA solution
NAO solution
CoA solution
Water

0. 20
0. 02
0. 0 5
0. 10
0. 025
1. 465

(2) MOH suspention

0. 01

(3)

cs suspension

(4) CAT solution

0. 02
0. 01

Final Con. in
assay mixture (mM)
100
10
1. 25
0. 5
0. 125
Vt =l. 96
5 µ. g. mL-1 = 5. 5 U. mL·1

10 µ. g. mL·1 = 0. 7 U. mL-1
5 µ. g. mL·1 = 0. 6 U. mL·1
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Table A 2 . 2
Example of an assay

No .

3 0 mM Ac-CNE

3 0mM Ac-CoA

µ L µmol ( µM )

µL

µmol ( µM )

1250

100

300

200

9.1

123 0

10 0

3 00

200

20

0 . 6 18 . 2

1210

10 0

300

200

1 . 2 36 . 4

40

1 . 2 36 . 4

117 0

10 0

300

20 0

60

1 . 8 54 . 5

60

1 . 8 54 . 5

113 0

10 0

3 00

200

80

2 . 4 72. 7

80

2.4 72. 7

109 0

10 0

3 00

20 0

3 . 0 9 0 . 9 10 0

3 . 0 90 . 9

1050

10 0

3 00

200

10 0

300

200

0

0

0

0

2 RS1

10

0.3

9.1

10

0.3

3RS2

20

0 . 6 18 . 2

4RS3

40

5RS4
6RS5

7RS6 10 0
8Sl

3 M
KHC03
( µ L)

0

0

1B

3 M
HC10
o . w . 10 %BSA
4
( µ L)
( µ L)
( µ L)

10 0 -10 0 0 µL
V1 = 1 . 65

RS = Refereced Standared, S = Sample
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Calculations

Extinction coefficient of NADH :
c = 6. 22 cm2 • µmole.1 at 340 nm
#1. Acetyl-CoA :
C

=

Where

x 2 ( µmole. cuvette·1 contents ]

6. 22
Q

=

/32 + 2 /3

/3 +

1

and

(3 =

#2. Acetylcarnitine + Acetyl-CoA :
C =

Where

6. 22
a =

x 2 ( µmole. cuvette contents·• ]
(/3') 2 + 2/3')
(3' + 1

and (3' =

The value for aceylcarnitine is found from the difference
between equations #2 and #1. If the sample contains · no

acetyl-CoA , @E2 = o , and the calculation is simplified.

Normal Values : Tissues of rats 377 ± 62 n mole per g of
frozen heart muscle and 41 ± 9 n mole per g of frozen liver.
Reference :

1. Pearson , D. J. , Tubbs , P. K. & Chase , J. F. A.
(1759) Canitine and acylcarnitines. In : Methods
of enzymatic analysis , Vol. 3 (Bergmers , H. v . ,
ed. pp. 1758-1818 , Verlay chemie Intern , Deerfield
Beach , Fla.

APPENDIX 3

ACETATE DETERMINATION

Acetate was determined by a enzymetic determination by
using acetyl-CoA synthetase as described by Guynn and Veech
(Mellanby & williamson 1974), with some modifications. The
acetate concentration was determinated as the difference in
the initial and final readings by using a potassium acetate
standard curve.
Principle
The method is based upon the enzyme sequence :
Acetate-

+

ATp4-

Acetyl-CoA
Malate2-

Net : Acetate-

+

+

+
+

CoA = AMP2-

+

pp4-

+

acetyl-CoA

oxaloacetate2- = citrate3- CoA

NAD + . = oxaloacetate2ATp4-

+
+

+

NADH

+

+

+

H+

H+

H+

malate2- + NAD + = AMP2pp4- + citrate3- + 3H + + NADH

The assay depends upon the conversion of acetate to
acetyl-CoA and the measurement of the acetyl-CoA by a
coupled system of malate dehydrogenase and citrate synthase.
Equipment
Spectrophotometer for measurements at 340 nm.
Reagents
a) Stored at 0-4 ° C
1. 0.2 M Tri-HCl, pH 8. 0 containing KCl, 0.1 M :
2. 0. 1 M Magnesium chloride :
3. 5.0 mM NADH, in 0. 3% (w/v) KHC03 , Stable for 5-7
days :
4. 1.2 M Perchloric acid :
b) Stored below -15 ° C
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5. 27 mM Adenosine 5'-triphosphate, Tris, Potassium or
sodium salt:
6. 24 mM NAO + , free acid:
7. 0. 1 M Malate, Potassium salt:
8. 1. 2 mM Coenzyme A, free acid, containing
3. 0 mM of mercaptoethanol, prepare fresh good for 1
week
9. Bovine serum albumin, 100 mg. mL-1 :
10. Acetyl-CoA synthtase:
Procedure
Preparation of reagent cocktail :
All reagents were prepared in deionized water and
neutralized when necessary with either HCl or KOH.
A cocktail was prepared containing 90 mmol Tris-HCl. L-1
(pHS), 2. 7 mmol ATP. L-1 , 0. 075 mmol NADH. L-1 , 0. 6 NAO mmol. L-1 ,
12 mmol coenzyme A. L-1 , o. 6 mmol malate. L-1 , 4. 5 mmol
magnesium chloride. L-1 , o. 3 mmol mercaptoethanol. L·1 , 45 mmol
potassium chloride. L·1 , 12 u. mL·1 malate dehydrogenase, 0. 5
u. mL·1 citrate synthase, and 50 mg ddialized BSA. mL-1 ( Table A
3 . 1) •

A standard curve was prepared by adding o, 25, 50, 100,
150, and 200 µl of 1 mM of potassium acetate standard to
tubes and made total volume 1 mL.
1 mL of standard and incubated hepatocyte supernatant
(SN) was centrifuged at 2o oox g for 10 min at 25 ° C.
0. 5 mL of SN filtrate was transferred to a cuvette and 1
ml of the cocktail was added. Each cuvette was mixed by
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inverting and the optical density (OD) was read in a
spectrophotometer at 340 nm (A 1 )
2µL of stock enzyme (36

.

u. mL-1 )

acetyl-CoA synthetase

was added to get 0. 075 u. mL·1 , mixed, and allowed to stand
for 40 min. The OD of the sample was again read at 340 nm
The acetate concentration was determined as the
difference in the initial and final readings (Ai- A 1 ) by
using a potassium acetate standard curve.
Reference :

1. Guynn, R. w. & Veech, R. L. (1975) Enzymatic
determination of acetate. In: Methods of enzymology,
vol. 35 (Lowenstein, J. M. , ed). pp. 302-7. Academic
press, New York, NY.

2. Bridges, s. R. , Anderson, J. w. , Deakins, D. A. ,
Dillon, D. W. & Wood, c. L. (1992) Oat bran
increases serum acetate of hypercholesterolemic men.
Am. J. Clin. Nutr. 56: 455-9.
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Table A 3.1
Preparation of A cocktail

9 0 nuno l Tris-HCl . L-1 (pHS ) :

2.7

nunol ATP . L-

Stok Cone .

uL/ 1 mL

Required con .
1

:

0 . 0 7 5 nuno l NADH . L-1 :
0 . 6 nuno l NAD . L-1 :

450
100

2 0 0 mM
2 7 mM

15

5 mM

25

2 4 mM

1 0 mM

o . 1 2 nunol coenzyme A . L- 1 :

12

0 . 6 nunol malate . L· 1 :

60

0. 1 M

4 . 5 nunol magnes ium chloride . L·1 :

50

0.1 M

100

0 . 3 mM

o . 3 nunol mercaptoethanol . L-1 :

1 M ·

4 5 nuno l potass ium chlor ide . L·1 :

45

5 0mg . mL-1 dialized BSA

20

1 0 % BSA

1 2 U . mL- 1 ma late dehydrogenase .

10

1000 U/mL

3

1 . 6 7 U/mL

0 . 5 U . mL-1 citrate synthase ,
0 . 07 5 U . mL- 1 Acetyl coA synthase

2

3 6 U/mL
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Table A 3 . 2
Bxaaple of an assay
w-std
1 mM K-Ac
No . ( µ l ) nmole
lB

0

0

Cock
tai l AcCoAs
(ml )
(ml )
(µl)

D.W

( ml )

Fina l
con .
( µM ]
0

Vt

1000

1000

20

1 . 50

2RS 1

25

25

975

1000

20

1 . 50

12 . 2 6

3RS2

50

50

950

1000

20

1 . 50

24 . 51

4RS3 1 0 0

100

900

1000

20

1 . 50

4 9 . 02

5RS4 1 5 0

150

850

1000

20

1 . 50

73 . 53

6RS5 2 0 0

200

800

10 0 0

20

1 . 50

98 . 0

7 Sl

5 0 0 µL

1000

20

1 . 50

A1

APPENDIX 4

ACETALDEHYDE DETERMINATION
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Principle
�=======0) CH3 COOH + NADH + H +
CH3 CHO + NAO + �
Although the equilibrium of the reaction lies in favour
of acetate and NADH, quantitative oxidation of acetaldehyde
is possible with the yeast enzyme. Therefore the rate of
reaction which is proportional to the aldehyde concentration
over a limited range, is used.
Equipment
Spectrophotometer for measurements at 34 0 nm.
Reagents
1. 0. 1 M Potassium chloride: Dissolve 74. 5 g KCL in
distilled water and make up to 1 L.
2. 1 M Tris buffer pH 8. 0: Dissolve 30 g tris in 150
mL distilled water, adjust to pH 8. 0 with 4 N HCL
and dilute to 250 mL with distilled water.
3. 0. 1 M EDTA: Dissolve 3. 7 g EDTA-Na2H2. 2H20 in
distilled water and make up to 100 mL.
4. 0. 1 M Mercaptoethanol: dissolve 0. 78 g
mercaptoethanol in distilled water and make up to
100 mL.
5. 15 mM P-NAD: Dissolve 100 mg NAO in distilled water
and make up to 10 mL.
6. NAO-buffer mixture: Immediately before use mix 3
volumes of solution 1, 6 volumes solution 2, 0. 5 volume
solution 3, 0. 5 volume solution 4, and 0. 5 volume
solution 6.
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7. 2 M Acetaldehyde stock solution: Prepare a 10 %
solution of freshly distilled acetaldehyde in
distilled water.
8. 5 U.mL� Aldehyde dehydrogenase: Thaw the frozen
enzyme solution and dilute accordingly with
distilled water.
Procedure

1. 2 mL of incubation SN was rapidly pipette into a
cuvette.
2. 1 mL of NAO-buffer mixture was added, mixed rapidly,
put on cuvette lid, and read extinction E 1 9
3. 0.025 mL Adehyde dehydrogenase suspension (150 U.3
mL-1 ) was added, mixed.
4. After exactly 10 min, read extinction Ei •
5. Calculation: @E = E1

-

Ei.
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Table A 4 . 1
Reaction mixture , sUJDll&ry of procedure
Pipette into cuvettes
mix.
Deproteinized, neutralized
Sample or Std.
HAD-Buffer Mixture
1 M KCl
3 p
1 M Tris buffer
6 p
(pH 8.0)
0.1 M EDTA
0.5 p
0.1 M Mercaptoethanol 0.5 p
15 mM /3-NAD
0.5 p
Read E 1 at 340 nm
Add aldehyde dehydrogenase

Vol. (mL) Con.in assay
2

94mM
1

0.189M
1.58mM
0.24mM

Vt = JmL
> 50 mU.mL-1
150 mu. J mL-1
0. 15 U. J mL-1

Mix, immediately start a stop watch and read E2 exactly
10 min. later
@E = E2 -E 1 is used for · the
calculations.
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Table A 4 . 2
Example of an assay

No .

w -

2 mM
{µL)

- is

Std
Acetaldehyde
{µmole)

0

D.W.
{mL)

NAO-Buffer
Mixture
{mL)

{µL)

0

2

1

30

2RS1

50

0.1

1 . 95

1

30

3RS2

100

0.2

1 . 90

1

30

4RS3

200

0.4

1 . 80

1

30

5RS4

300

0.6

1 . 70

1

30

6RS5

400

0.8

1 . 60

1

30

7RS6

500

1

1. 5

1

30

1

30

Sl

up to 2 mL

Reference :
1 . Lundquist, F . {1974) Determination with
dehydregenase . In: Methods of enzymology, vol 3
{Lowenstein, J . M . , ed) . pp . 1509-1513 . Academic
press, New York, NY .

APPERDIX 5

ACETOACETATE DETERMINATION
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Acetoacetate was determinated by the fluorescent
spectrophotometry method (Mellanby and Williamson 1974).
The decrease in NADH concentration was measured by the
decrease in fluroescence as acetoacetate was reduced to 3Hydroxybutyrate.
Principle

3-HBDB

D- (-)-3-Hydroxybutyrate + NAD +
Acetoacetate + NADH + H +
Reagents

1. 1 M K2HP04 • NaH2P04 (pH 7. 0) : Dissolve 21. 8 g K2HP04
and 19. o g NaH2P04 2H20 in 200 mL of double
distilled water adjust pH to 7. 0 as necessary with
4 M KOH and bring up to 250 mL with double
distilled water. Store at 4 ° C.
2. 5 mM NADH: Dissolve 3. 5 mg P-NADH-Na2 , Grade I I I
from yeast (Sigma, St. Louis, MO) per mL of
carbonate buffer. Heat to 60 ° C for 15 min and
store at -20 ° C. Make fresh weekly.
3. 0. 1 M Na2C03 • NaHC03 (pH 10. 6): Dissolve O . 85 g Na2C03
and 0. 17 g in 75 mL double distilled water adjust
pH as necessary with 4 M KOH and bring up to 100 mL
double distilled water. Store at -20

°c .

4. 20 mM Tris Buffer ( pH 8. 0): dissolve 0. 24 g
Tris (Sigma, St. Louis, MO) in 75 mL of double
distilled water adjust pH to 8. 0 with 1 M HCl add
200 µL 10% BSA and bring to 100 mL. Store at -20
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5. 3-Hydroxybutyrate Dehydrogenase. type I I from
Rhodopseudomonas spheroides in 3. 2 M (NH4)2 S04 (
Sigma, St, Louis, MO).
6. 1

mM

Acetoacetate: Dissolve 11. 5 mg Acetoacetic

acid- Lithium salt ( Sigma, st. Louis, MO) per mL
double distilled water. This yields a 110
solution. Dilute to 1

mM

mM

by adding 100 µL to 9. 9 mL

double distilled water.
7. 3 M HCl04: Dilute 25 mL 70% HCl04 to 100 mL with
double distilled water. Store at 4 ° C.
8. 10% BSA : Dissolve 10 g BSA in 75 mL double
distilled water bring to 100 mL with double
distille water.
9. 3 M KHC03 : Dissolve 30 g of KHC03 in double
distilled water and make up to 100 mL. Store at -20
oc.

10. Reagent Mixture: Add 10 mL 1 M phosphate buffer and
100 µL of 5 mM NADH to 90 mL double distilled
water. Prepare fresh daily.
Procedure
1. A standard curve was prepared by adding

o , 10, 20, 40,

60, 80 and 100 µL (Fig. A 5. 1) of acetoactate standard to
tubes containing 100 µL 10% BSA, 300 NL 3 M HC104 and
double distilled water to a total volume of 1. 65 mL.
2. The tubes were vortexed vigorously for 30 sec and

12 2

1 20

y=

- 6.475 1 + 43. 1 755x R

z::

0.99

1 00

80

60

40

20

0 ..__.L_�---.-----,----.---r-----,
3

0

Ac et oa ce tate

2

( nmo l . mL )

FZGURE A s . 1 Acetoacetate standard curve
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allowed to sit in an ice water bath for 5 min vortexed
again and centrifuged for 10 min at 1500 x g at 2 ° C.
3. The supernatant was then poured off into another tube on
ice.
4. A 100 µL aliquot of the neutralized standard or tissue
supernatant was added to 1. 9 mL of reaction mixture in a
4. 5 mL polystyrene Ultra-Vu disposable cuvette (Baxter
Scientific Products, Atlanta, GA) and mixed by
inversion.
5. Baseline fluorescence was determined in a Hitachi F-2000
Fluorescence Spectrophotometer (Exitation 360 and
Emission 400 nm) 10 µL of BHBDH was then added.
6.

The cuvettes were mixed by inversion and let sit at room
temperature for 60 min in the dark.

7.

After 60 min fluorescence was determined again. The
decrease in fluorescence was proportional to the
concentration of acetoacetate.

Calculations

Fluorescence x 1. slope x 5 = nmoles. mL·1 SN

Fluorescence x 1. slope . mg liver = nmoles. mg·1 liver

Fluorescence x 1. slope x 10 = nmoles. mL·1 urine
Reference :

1. Mellanby, J. & Williamson, D. (1974) Acetoacetate In:
Methods of enzymatic analysis (Bergmeyer, H. u . ed)
vol. 4. pp. 1840-1843. Verlag Chemie. Intl. Deerfild
Beach, FL.

APPENDIX 6
3-HYDROXYBUTYRATE DETERMINATION
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3-Hydroxybutyric acid was determined according to the
procedure of Williamson and Mellanby (1974) adapted for
spectrophto fluorometer. The concentration of NADH is
measured by an increase in fluorescence as 3-Hydroxybutyrate
is oxidized to acetoacetate.
Reagents
1. 1 M 2-Amino-2-methyl-l-propanol buffer (pH 10):
Dissolve 8. 9 g 2-amino-2-methyl-1-propanol (9. 5 mL
if liquid) in double distilled water, adjust pH to
10 with 12 M HCl and dilute to 100 mL with double
distilled water. Store at -20 ° C.
2. 20 mM Tris buffer (pH 8): Dissolve 0. 24 g
Tris (Sigma, st. Louis, MO) in double distilled
water adjust pH to 8 with 1 M HCl add 200 µL 10% BSA and
dilute with distilled water to 100 mL.

Store at -20 ° C.

3. 20 M Hydrazine hydrate: (Sigma, St. Louis, MO)
4. 0. 1 M P-Nicotinamide dinucleotide (Grade I I I) from
yeast (Sigma, st. Louis, MO): Dissolve 70 mg NAD in
1 mL double distilled water. Store at -20 ° C.
5. Lactate dehydrogenase, LOH: Dilute stock LDH,
Bovine heart Type I I I in 2 . 1 M (NH4)2 S04 (Sigma, St.
Louis, MO) with 20 mM Tris buffer.
6. 1 mM 3-hydroxybutyrate: Dissolve 15. 4 mg DL-3hydroxybutyric acid-sodium salt (Sigma, St. Louis,
MO) per mL double distilled water this yields a 0. 1
M solution. Dilute to 1 mM by adding 200 µL to 9. 8
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mL double distilled water. Make fresh daily.
7. 3 M Perchloric acid: Dilute 25 mL of 70% HC104 with
double distilled water to · 100 mL .
8. 3 M Potassium hydrogen carbonate: Dissolve 30 g
KHC03 with double distilled water and make up to
100 mL.
9. Reagent mixture: Mix 10

mL

buffer (l), 250 µL

Hydrazine hydrate and 50 µL NAD and bring to 100 mL
with double distilled water. Make fresh daily.
Procedure
1. A standard curve was prepared by adding

o , 10, 20, 40,

60, 80 and 100 µL (Fig. A 6. 1) of 3-Hyfroxybutyrate

standared to tubes containing 100 µL 10% BSA, 300 µL 3 M
HC104 and double distilled water to a total volume of
1. 65 mL.
2. The tubes were vortexed vigorously for 30 sec and
allowed to sit in an ice water bath for 5 min, vortexed
again and centrifuged for 10 min at 1500 x g at 2 ° C.
3. 1 mL of the supernatant was removed and added to another
to another conical tube on ice. 200 µL of 3 M KHC03 were
added and allowed to sit for 15 min, then centrifuged
for 10 min at 1500 x g at 2 ° C. The supernatant was then
poured off into another tube on ice.
4. A 100 µL aliquot of the neutralized standard or
tissue supernatant was added to 1. 9 mL of reaction
mixture in 4. 5 mL polystyrene Ultra-vu disposable
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FIGURE A 6 . 1 3-Bydroxybutyrate standard curve
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cuvette (Baxter Scientific Products, Atlanta, GA) and
mixed by inversion.
5. Baseline fluorescence was determined in a Hitachi F-2000
Fluorescence Spectrophotometer (Exitation 360 and
Emission 460 nm). 10 µL of BHBDH were then added, the
cuvettes were mixed by inversion and let sit at room
temperature for 60 min in the dark.
6. After 60 min fluorescence was determined again. The
decrease in fluorescence was proportional to the
concentration of 3-Hydroxybutyric acid.
Calculations
Fluorescence x 1. slope x 5 = nmoles. mL·1 SN
Fluorescence x !. slope. mg liver = nmoles. mg� liver
Fluorescence x 1. slope x 10 = nmoles. mg·1 liver
Reference :
1. Williamson, D. H. & Meanby, J. (1974) D- (-)-3Hydroxybutyrate. In : Methods of enzymatic analysis
(Bergmeyer, H. U. ed. ), Vol. 4 pp. 1836-1839. Verlag
Chemie Intl. Deerfild, FL.

APPENDIX 7

ACBTYLCAIUfITINB BINDING STUDY

13 0
1 . SYNTHES IS OF [ 1- 14C ] ACETYLCARNITINE

Principle
Carnitine

+

C-acetyl-CoA

14

Camitine acyltnm.sferue

-------------->
+

14

c-acetylcarnitine

Free CoA

+

C-acetyl-CoA

14

Anion Exchange

acetylcarnitine

w

Procedures
1. Incubate the total volume 3. 5 mL of incubation
mixture (Table AVII. 1) at 30 ° C for 60 min.
2. Terminate reaction with 200 µL of 36% of perchloric
acid.
3. Cool it up and neutralize acidic soup with 300 µL of
4 N KOH followed by centrifugation.
4. Take supernatant and pass through anion exchange

colum (0. 5 x 6 cm) of AG 2- x a , c1- form, 200-400

mash in water.
5. Elutriate ( 1- wC ] Acetylcarnitine with 3 times with
0. 5 mL of water. ( yield 85%)
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Table A 7.1.
coapositions of incubation aixture
Ingredient
[ 1-14c J acetyl-CoA
( 50 µ.Ci. µ.mole)

µ.mol. L-1
171

µ.mol.mL·1
0.171

µ.mol.3. 5 mL·1
0.595

L-Carnitine

157

oxidized Glutathione

5000

5

17.5

EDTA (EthyleneDiamine
-TetraAcetate)

1000

1

3. 5

Potassium phosphate
( pH = 7.4)

100,000

100

350

CAT (Carnitine
Acyl-Transferase)
Reference

0. 157

0. 549

4 Units

1. Murthy, M. s. R. & Pande, s. V. (1984) Mechanism of
carnitine acylcarnitine translocate-catalyzed import of
acylcarnitines into mitochondria. J. Biol. Chem. 259:
9082-9089.
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2 . Binding study
1. In a 1. 5 mL micro centrifuge tubes (conical bottom
with attached closure) the total volumes of 0. 5 mL
contained sodium pyrophospate buffer, pH 7. 4 (55
mmol. L-1 )

,

NAO (0, 1, 2, 4 umol. L-1 )

glutathione (1. 1 mmol. L-1 )

,

,

reduced

[ 1- 14C ] -acetylcarnitine

(2 umol. L-1 , specific radioactivity 123, 659
dpm. nmole or 2061 Bq. nmole), and horse ADH (0. 17
unit or 100 ug protein).
2. The reaction mixture (Table AVI I . 2) was incubated for 5
min at 37 ° C in a Dubnoff metabolic shaking water
bath (80 oscillation. mi�1 )

.

3. The reaction mixture was transferred to an 30, 000
NMWL Ultrafree-MC filter unit (Millipore, Bedford,
MA) and centrifuged at maximum speed {15, 000 x g)
for 5 min in an Eppendorf centrifuge, model 5412 ·
(Sybron/Brinkmann Instruments, Westbury, NY).
4. The residue on membrane sample cup was transferred
to a scintillation vial containing 5 mL
scintillation fluid and the radioactivity was
counted in a Beckman LS 3801 Liquid Scintillation
counter.
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Tabla A 7 .2
Incubation mixture for binding study
Tube No .

1

Mixture

2

3

4

(mL)

Buffer ( pH7 . 4 )
7 5 mmol . L-1

0 . 37

0 . 37

0 . 37

0 . 37

NAO
( 1 0 0 µ mol . L-1 )

0

0 . 005

0 . 01

0 . 02

Reduced
Glutathione
( 1 0 0 mmol . L-1 )

0 . 0055

0 . 0055

0 . 0055

0 . 0055

Horse ADH
( 10 0 µg protein
or 0 . 1 7 unit )

0 . 01

0 . 01

0 . 01

0 . 01

0.1

0. 1

0. 1

0 . 015

0 . 01

0

[ 1 - 1•c 1 acetylcarnitine
( 12 3 , 6 5 9 dpm . nmole 0 . 1
or 2 0 6 1 Bq . nmole )
G. D.W.

0 . 02

APPENDIX 8
ADB IBBIBITORS

TABLE A8 .1
Inhibitors of ADH

Ki

Inhibitor
Pyrazol
4-Metyl pyrazol
4-Propyl pyrazol
4-Pentyl pyrazol
Benzamide
Isobutyramide
Auramine

competition

0. 22 Sub.
It
0. 013
It
0. 004
It
0. 000

.

530

Sub .

9

It

14 0

2, 2, -Bipyridine
Phenanthroline
Imidazoie
Primaquine
Quinoline derivatives
Amphetamines
Propranolol
Folic acid
Flavensomycin
metronidazole

Cosub.
It

Mode of action

Ref#

Form terary complexes with AOH and NAO
Heterocyclic ring of pyrazol forms a bridge
through its two nitrogen atoms and the catalitic
zinc atom and C-4 of the nicotinamide moiety of
NAO
Ternary complexes with AOH and NAOH

2
6
7
3

Form strong and specific complexes with AOH
in the absence and presence of coenzyme

2

Bind of AOP-ribose and coenzyme fragments

2

Bind to the active zinc atoms and ternary
complexes (AOH, AOP. ribose, and phenanthroline)

1
4

Sub. & Cosub. Form the binary complexes of ADH and imidazole
also form ternart complexes (ADH, imidazole, NAO)
in the presence of coenzyme.
Without characterization of the mode of
inhibition

2
8

7

2

...

w
UI
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